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1. Summary  1 
Pneumonia remains the leading cause of hospitalizations and deaths in children 2 
<5 years. A variety of respiratory pathogens cause acute respiratory infections 3 
including pneumonia. However, their associations with death are still not well 4 
defined. I analyzed viral and bacterial pathogens and other risk factors associated 5 
with fatal outcomes among children hospitalised in the Philippines.  6 
Children aged <5 years with a clinical diagnosis of severe pneumonia were 7 
recruited in four hospitals in the Philippines from 2008-2016. Nasopharyngeal 8 
swabs were collected for virus identification by polymerase chain reaction 9 
(PCR), and venous blood samples were collected for bacterial culture. 10 
Demographic information, clinical data, and laboratory findings were also 11 
collected at the admission. Univariate and multivariate logistic regression 12 
analyses were performed to identify the factors associated with death. 13 
A total of 5,054 pneumonia cases were recruited, and 68.9% of them were aged 14 
less than one year, 55% of death cases were malnourished, and 13% were 15 
hypoxemic (SpO2 <90%). Children aged <24 months accounted for 87.0% of the 16 
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fatal cases with the age group of 2-5 months having the highest CFR of 7.0%. A 17 
significant decreasing trend of CFR was observed during the 9-year study period 18 
with the highest CFR of 12.5% in 2008 and the lowest CFR of 2.0% in 2013 (p 19 
<0.001). At least one virus was detected in 61.0% cases; respiratory syncytial 20 
virus (RSV) (27.0%) and rhinovirus (RV) (23.0 %) were the most common 21 
viruses. In children aged 2-59 months, risk factors significantly associated with 22 
death included sensorial changes, severe malnutrition, grunting, central cyanosis, 23 
decreased breath sounds, tachypnea, wheeze, fever (≥ 38.5°C), SpO2<90%, 24 
infiltration, consolidation and pleural effusion on chest radiograph. Among 25 
pathogens, adenovirus (ADV), particularly ADV-7, seasonal influenza A (H1N1) 26 
and blood culture positive for invasive bacteria were significantly associated with 27 
deaths, while RSV (AOR: 95% CI 0.31;0.19-0.5) and RV (AOR: 95% CI 0.99; 28 
0.68-1.41) were not associated with death. Similar patterns were observed 29 
between death cases and these aforementioned factors in children <2 months. 30 
Hypoxemia was associated with death in RSV, RV, enteroviruses positive 31 
patients.  32 
Malnutrition was the most common factor associated with death and addressing 33 
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this issue may decrease the case fatality rate. Since 13% of patients were 34 
hypoxemic, evaluation of hypoxemia by a pulse oximeter should be promoted. 35 
Oxygen therapy should be administered in patients with hypoxia, since it appears 36 
that hypoxia is one of the driving factors for fatal outcome especially in children 37 
with viral infections. In general, viral infections did not increase the risk of fatal 38 
outcomes except for ADV and seasonal influenza A (H1N1). Appropriate 39 
measures including early detection and early treatment for bacterial pneumonia 40 
should be taken considering high CFR among blood culture positive cases.  41 
 42 
Key words: childhood pneumonia; death; association; oxygen; saturation; 43 
viruses; bacteria; chest radiograph. 44 
 45 
 46 
 47 
 48 
 49 
 50 
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Abbreviations 51 
AOR: adjusted odds ratio.  52 
OR: odds ratio.  53 
CFR: case fatality rate.  54 
ADV: Adenovirus;  55 
PCR: Polymerase chain reaction.  56 
RT-PCR: Real-time polymerase chain reaction.  57 
RSV: Respiratory syncytial virus.  58 
RV: Rhinovirus.  59 
HMPV: Human Metapneumovirus.  60 
PIV: Parainfluenza virus.  61 
IFV: Influenza virus.  62 
EV: Enterovirus  63 
EV-D68: Enterovirus-68 64 
LMIC: Low and middle-income countries. 65 
 WHO: World Health Organization. 66 
 IMCI: Integrated Management of Childhood Illness.  67 
ALRI: Acute lower respiratory infection. 68 
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 BPH: Biliran Provincial Hospital.  69 
EVRMC: Eastern Visayas Regional Medical Center.  70 
ONP: Ospital ng Palawan.  71 
RITM: Research Institute for Tropical Medicine.  72 
RR: Respiratory rate.  73 
SpO2: Blood oxygen saturation.  74 
SES: socio-economic status 75 
  76 
 77 
 78 
 79 
 80 
  81 
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3. Introduction  82 
Globally, pneumonia accounts for a substantial burden of disease and mortality 83 
among children less than 5 years. Around 120 million pneumonia episodes 84 
occurred every year, of which 14 million (12%) progress to severe pneumonia
1
. It 85 
is estimated that 5.6 million children died in 2016 before their fifth birthday. 86 
Pneumonia accounted for 896,000 of these deaths
2
 and 81% of them occurred 87 
among children aged less than 2 years. Around 99% of childhood pneumonia 88 
deaths occur in low and middle-income countries (LMIC) 
1
. In the Philippines, a 89 
community-based study conducted from June 2011 to May 2012 reported 90 
incidence rates of pneumonia-like episodes, severe pneumonia-like episodes, and 91 
pneumonia-associated deaths were 105, 61 and 0.9 per 1,000 person-years, 92 
respectively 
3
. 93 
There are several challenges for tackling childhood pneumonia mortality in 94 
resource-limited settings. Risk factors such as poverty 
4
, household crowding, 95 
malnutrition, and solid fuel use for cooking 
3 5-7
, and HIV-AIDS mainly in sub-96 
Saharan 
8
 are associated with childhood pneumonia mortality. Despite the high 97 
burden of childhood pneumonia, its diagnosis remains difficult and largely based 98 
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on clinical signs and symptoms [9]. Integrated Management of Childhood Illness 99 
(IMCI), which was developed by the World Health Organization (WHO) and 100 
UNICEF has been widely used for better management of common childhood 101 
illnesses including pneumonia in LMIC and was modified in 2014
9 10
. However, 102 
IMCI and other cases definitions use clinical signs and symptoms that are not 103 
specific to pneumonia. Several other conditions such as bronchiolitis, measles, 104 
and malaria may have similar clinical features
11-15
. Determining the etiology of 105 
pneumonia is also challenging in the absence reliable laboratories 
16
, and lack of 106 
access to any form of diagnostic imaging in most of primary care settings in 107 
LMIC 
17
, although chest radiograph is an important tool for diagnosis of 108 
pneumonia. 109 
 Several groups of pathogens can cause pneumonia. Bacteria are considered to be 110 
an important aetiology for childhood pneumonia, and bacterial infections have 111 
been shown to be associated with mortality 
18 19
. One of the main strategies for 112 
pneumonia treatment of IMCI is to treat a patient presenting severe or very 113 
severe pneumonia with appropriate antibiotics
9 10
. Vaccines against Haemophilus 114 
influenzae type b and Streptococcus pneumonia have been introduced in many 115 
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LMIC, which are shown to have reduced morbidity and mortality of childhood 116 
pneumonia 
2 20-23
, and has decreased the incidence of radiologic pneumonia. 117 
24
.  118 
Viruses are the most common group of pathogens identified from children with 119 
acute lower respiratory infection (ALRI) including pneumonia
25
. Findings of 120 
previous studies, in which conventional virological diagnostic techniques such as 121 
virus isolation and immunofluorescence staining were used, are likely to 122 
underestimate the role of viruses as a cause of pneumonia 
26
. It is known that at 123 
least 26 viruses can cause childhood pneumonia 
25
 and respiratory syncytial virus 124 
(RSV) is one of the most common viruses detected from children with ALRI. 125 
Most recent estimates on the global burden of RSV indicated that 33.1 million 126 
episodes of RSV associated ALRI (RSV-ALRI) with 59,600 in-hospital deaths 127 
among children less than five years in 2015
27
. About 45% of hospital admissions 128 
and in-hospital deaths due to RSV-ALRI occur in children younger than 6 129 
months. In high-income countries, most deaths associated with RSV occur in 130 
children with comorbidities 
28 29
. Influenza virus (IFV) infection has also been 131 
shown to have a significant impact on children worldwide with estimated 28,000-132 
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111,500 deaths in children younger than five years 
30
. Other common viruses 133 
identified from ALRI include rhinovirus (RV), human metapneumovirus 134 
(HMPV), parainfluenza virus (PIV), and adenovirus (ADV) 
31-33
. More recently, 135 
enterovirus D68 (EV-D68) was shown to be associated with ALRI 
34
. However, 136 
the impact of these viral infections on childhood pneumonia mortality in a 137 
hospital setting is still not well characterized.  138 
Some risk factors and clinical signs including nutritional status
1 35
, low 139 
birth weight 
36
, cyanosis and grunting 
37
, and radiological findings such as chest 140 
X-ray consolidation 
38
 are well described as predictors of death in childhood 141 
pneumonia. Nonetheless, further reduction of childhood pneumonia mortality 142 
requires a better understanding of the association between death and viral 143 
infections as well as an update of all factors associated with death in general.  144 
3. Objectives 145 
 The objective of this study was to define the etiological, demographic and 146 
environmental factors and clinical findings associated with mortality among 147 
children hospitalised with pneumonia in the Philippines. 148 
5 .Material and methods 149 
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5.1 Study design: This is a case series study of hospitalised pneumonia cases, 150 
which is a part of the large comprehensive epidemiological and etiological study 151 
on acute respiratory infections in children. 152 
5.2 Study sites 153 
Paediatric pneumonia cases were enrolled between May 2008 and March 2016. 154 
This study was done in the following 4 hospitals in the Philippines: Biliran 155 
Provincial Hospital; Eastern Visayas Regional Medical Center; Ospital ng 156 
Palawan; and Research Institute for Tropical Medicine. Biliran Provincial 157 
Hospital (BPH) is the main hospital in Biliran Island with 50 pediatrics beds. 158 
Eastern Visayas Regional Medical Center (EVRMC) is a tertiary care 159 
government hospital in Central Philippines with a 250-bed capacity including 50 160 
paediatric beds. Ospital ng Palawan (ONP) is a secondary referral government 161 
hospital in Western Philippines with 40 beds in the paediatric department. ONP 162 
has around 500 patients in the paediatric department each year. Research Institute 163 
for Tropical Medicine (RITM), which is located in Metro Manila, has a 164 
specialized tertiary care hospital with 50 beds, 28 doctors and 62 nurses. RITM 165 
has around 500 patients per year. The study periods varied among hospitals with 166 
BPH from September 2012 to March 2016, EVRMC from June 2008 to Jan 2015, 167 
ONP from August 2012 to February 2015, and RITM from September 2012 to 168 
January 2015 (Figure 2). 169 
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5.3 Study patients 170 
Children aged from 8 days to less than 5 years who were hospitalised in the 171 
above facilities with acute respiratory symptoms were assessed by using the 172 
IMCI algorithm by trained study physicians
9
. Patients who were assessed to have 173 
severe pneumonia or very severe disease by the IMCI algorithm were recruited 174 
for the study. In 2014, the IMCI algorithm for acute respiratory infection was 175 
revised, and children with chest indrawing are no longer diagnosed as severe 176 
pneumonia and do not require hospitalization. However, this new algorithm had 177 
not been widely implemented in the study sites during the study period, and 178 
patients with chest indrawing and those with danger signs continued to be 179 
recruited based on the previous IMCI algorithm. Exclusion criteria included 180 
children aged less than 7 days old or 5 years or more, children admitted for 181 
another illness and who had developed symptoms of pneumonia during 182 
hosipitalization, children who had been admitted to another hospital within the 183 
last 3 days prior to present admission and children who had prior hospital 184 
admission without one week symptom free period when readmitted to the 185 
hospital.  186 
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Patient outcomes were grouped into two categories, survived and deceased. 187 
Survived group included discharged cases and discharged against medical advice 188 
with improved conditions. The deceased group included those who deceased 189 
during the hospitalization and discharged against medical advice with a 190 
deteriorated condition on their last clinical assessment. Congenital abnormalities 191 
included congenital heart disease, trisomy 21 syndrome, cerebral palsy or other 192 
neurodevelopmental conditions, and inherited haemolytic anaemia. Tachypnea 193 
was defined as follows: respiratory rate (RR) ≥60 breaths per minute (min) in 194 
children <2 months, RR ≥50 breaths per min in children 2‒11 months, and RR 195 
≥40 breaths per min in children ≥12 months 39. Tachycardia was defined heart 196 
rate ≥180 beats per minute (bpm) for children <12 months old and ≥140 bpm for 197 
children older than ≥12 months. The WHO child growth standards were used to 198 
evaluate the nutritional status of the child by computing the Z-scores of weight-199 
for-age and height-for-age
40
. Blood oxygen saturation (SpO2) was measured on 200 
admission by using a pulse oximeter (Handheld Pulse Oximeter PalmSAT 2500A 201 
with Finger Clip Sensor (Paediatrics), Nonin Medical, Inc.). Venous blood 202 
samples were also collected. The level of hemoglobin <8g/dL was classified as 203 
severe anemia.  204 
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5.4 Collection of patient information 205 
A standardized questionnaire was used to collect the socio-demographic and 206 
environmental data of households only for children recruited from February 2014 207 
to March 2016. A Simple Poverty Scorecard for the Philippines developed by 208 
Mark Schreiner
3
 was used to assess the socio-ecomonic status (SES) of the 209 
household. This score uses 10 simple questions (the number of children per 210 
household, school attendance of the children, female head’s education level, 211 
employment salary, material of the house’s roof and walls, the type of toilet 212 
facility, and possession of a refrigerator, television, or washing machine), and the 213 
scores range from 0 to 100. Households with an SES score <30 were defined as 214 
being in extreme poverty. A physical examination was conducted by a trained 215 
study physician, which included an examination of neck rigidity, sensorial 216 
changes, grunting, decreased breath sounds, chest indrawing, rales, central 217 
cyanosis, and nasal flaring. The following signs were considered as sensorial 218 
change: irritability, drowsiness, and stupor. The Glasgow coma scale was used 219 
for the assessment of coma and impaired consciousness
41
. Glasgow coma scale 220 
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<9 was considered to indicate severe condition, while the scale of 9–12 was 221 
considered to indicate moderate condition. 222 
5.5 Assessment of chest X-ray 223 
Anteroposterior and lateral chest radiographs were obtained. The image was 224 
interpreted by a designated radiologist trained for the standard interpretation of 225 
chest radiographs for the diagnosis of childhood pneumonia, as developed by the 226 
WHO Pneumonia Vaccine Trial Investigators’ Group42. The chest X-ray findings 227 
included end-point consolidation, other infiltrates and pleural effusion, and end-228 
point pneumonia was defined as the presence of end-point consolidation or 229 
pleural effusion.  230 
5.6 Detection of viruses 231 
After the sample collection, nasopharyngeal swabs (NPS) in viral transport 232 
medium were stored at 4°C in different sites and transported with ice packs to 233 
RITM in Manila for further analysis twice a week. Viral RNA and DNA were 234 
purified using the QIAamp MinElute Virus Spin Kit. Viral RNA was reverse 235 
transcribed to complementary DNA by the Moloney Murine Leukaemia Virus 236 
Reverse Transcriptase with random hexamer primers. RSV, HMPV and PIV 237 
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were detected in the samples by multiplex polymerase chain reaction (PCR) 238 
using two systems. The first system was for detection of RSV and HMPV. The 239 
second system was for detection of PIV-1, -2, -3 and -4. RSV positive samples 240 
were further subtyped into RSV-A and RSV-B by performing the nested PCR
43-46
. 241 
RV and enterovirus (EV) were detected from clinical samples by targeting 5’ 242 
Noncoding Region (NCR). The RV species (A, B, C) and serotypes of EV 243 
including EV-D68 were further identified by sequencing and phylogenetic 244 
analysis of 5’ NCR. RT-PCR was performed for the detection of IFV 245 
A(H1N1)pdm09, IFV A(H3N2) and IFV B
47
. ADV detection was performed by 246 
combining viral isolation and neutralization test as well as PCR and serotyping 247 
by sequencing
48-50
.  248 
5.7 Detection of bacteria 249 
Blood drawing for bacterial identification was done after obtaining consent from 250 
caregivers. One mL of venous blood was aseptically collected from patients on 251 
admission, and inoculated into a bottle containing 20 mL of brain-heart infusion 252 
broth with 1% gelatin, 0.125% sodium polyanethol sulfonate, and 0.1% agar. 253 
Samples were incubated at 36°C for seven days and subcultures were conducted 254 
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on sheep blood, chocolate, and MacConkey agar plates after 18 hours and 3, 5, 255 
and 7 days of inoculation. Plates were cultured at 36°C in a candle jar for 2 days. 256 
All isolates were stored in the skim milk at −20°C and transported to RITM for 257 
confirmatory tests. For confirmatory test for Burkholderia cepacia group, isolates 258 
were sent to Miroku Medical Laboratory in Nagano, Japan, and underwent 259 
sequencing for 16S rRNA. It was considered bacterial culture positive if at least 260 
one of the following 12 bacteria was identified; Acinetobacter baumannii (A. 261 
baumannii), Burkholderia cepacia (B. cepacia), Enterobacter aerogenes (E. 262 
aerogenes), Haemophilus influenzae (H. influenzae), Klebsiella pneumoniae (K. 263 
pneumoniae), Staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. 264 
aeruginosa), Pseudomonas stutzeri (P. stutzeri), other Pseudomonas species (P. 265 
spp.), Streptococcus pneumoniae (S. pneumoniae), and Onchrobactrum anthropi 266 
(O. anthropi). 
31
. Due to the high carriage rates of certain bactearia in the upper 267 
respiratory tract and low diagnostic value of bacterial culture using NPS, bacteria 268 
were not tested for NPS 
51
. 269 
 Virus-bacteria co-detection was defined positive for at least one virus and one 270 
pathogenic bacterium and virus-virus co-detection was defined as patient with 271 
two or more viruses detected. Patients whose samples were negative for any of 272 
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the target viruses and bacteria by blood culture were considered negative for all 273 
pathogens.  274 
 275 
5.8 Data analysis 276 
Outcome:  277 
Patient outcomes were grouped into two categories: survived and deceased. The 278 
survived group comprised of patients who were discharged, including those 279 
discharged against medical advice but with improved conditions. The deceased 280 
group comprised of patients who deceased during the hospitalisation period or 281 
were discharged against medical advice (DAMA)with a deteriorated condition on 282 
their last clinical assessment. We considered the worse cases scenarios by 283 
assuming that patients who were DAMA with deteriorated condition were all 284 
going to die. 285 
 The survived group included who were discharged and observed cured and those 286 
who were DAMA cases but with improved condition at their last examination. 287 
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The data were analysed based on two age groups, children <2 months and 2-59 288 
months according to the IMCI guidelines.
10 52
.  289 
To investigate the etiologic and clinical factors associated with fatal outcomes, a 290 
generalized linear model was applied. This model was adjusted for the age of 291 
patients, the year of sampling, and the hospitals where patients were admitted. A 292 
second model was also applied where the association of death was evaluated in 293 
the context of the clinical and radiological findings in 6 separate groups of 294 
children including those positive for RSV, RV, ADV, EV, bacteria in blood and 295 
negative for any viruses. The second model was adjusted for the age of patients, 296 
the year of sampling, and the hospitals after matching with the age groups. The 297 
extent of association with the fatal outcome in both models was evaluated by 298 
calculating the odd ratios (ORs) and 95% confidence interval (C.I.) using a 299 
simple exact binomial calculation. Fisher exact test was applied to compare the 300 
frequencies and Welch’s t-test or Brunner-Munzel test was used to compare the 301 
means and medians of variables between the two groups. P-value <0.05 indicated 302 
statistical significance. The comparison of CFRs by the year was examined using 303 
the Cochran-Armitage Test for Trend. Missing data were not included in analysis. 304 
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All statistical analyses were performed using Microsoft R Open 3.2.4 and Dplyr 305 
package
53
. 306 
 307 
5.8 Ethical considerations 308 
The study protocol was approved by the Ethics Committee of Tohoku University 309 
Graduate School of Medicine and the Institutional Review Board of RITM. 310 
Written informed consent was obtained from the parents or guardians of children 311 
who participated in the study.  312 
 313 
6. Results 314 
6.1 Demographic, clinical and radiographic findings.  315 
From 2008 to 2016, 5,128 children were enrolled in the study (Fig. 2). Of these, 316 
the outcome was available for 5,054 (98.6%) children, while 74 (1.4%) children 317 
were excluded from the analysis due to loss to follow-up, unknown outcome, or 318 
transferred to another hospital. Out of the 5,054 patients analysed, 749 (14.8%) 319 
were <2 months and 4,305 (85.2%) were aged 2-59 months old.  320 
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The case fatality rate (CFR) was slightly higher in patients aged <2 321 
months than in those aged 2-59 months (5.3% vs. 4.6%) and declined as the age 322 
of children increased. Children aged <24 months accounted for 87.0% of the fatal 323 
cases with the age group of 2-5 months having the highest CFR of 7.0% (Table 324 
2). Similar patterns were also observed when analysis was done without 325 
including DAMA cases (Table 8).  326 
There were more male patients (n=2876, 56.9%) than female patients 327 
(n=2178, 43.1%), although there was no significant association between the 328 
gender and outcome in both age groups (Table 2). A significant decreasing trend 329 
of CFR was observed during the 9-year study period, with the highest CFR of 330 
12.5% in 2008 and the lowest CFR of 2.0% in 2013 (p <0.001) (Table 1). 331 
EVRMC showed the highest CFR among the hospitals in both age groups (<2 332 
months, 7.8% and 2-59 months, 5.7%) and presented its highest CFR (12.5%) in 333 
2008 and the lowest in 2013(1.1%). 334 
 CFRs were lower in BPH (3.2%) and ONP (2.1%). The median days of 335 
hospitalization was longer in patients aged <2 months than those aged 2-59 336 
months (7 vs 4 days) (Table 2). The presence of congenital abnormalities was 337 
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associated with the fatal outcome for both age groups (p <0.05). Severe 338 
underweight for age (<-3SD) was observed in 41.2% of the fatal cases in patients 339 
aged <2 months, and in 39.2% of the fatal cases in patients aged 2-59 months. 340 
The history of child loss in the family was more frequent in fatal cases than in the 341 
survived group for children aged 2-59 months (33.3% vs 10.2%, p =0.003). 342 
Charcoal and wood were used as the cooking fuels by 86.5% of patient’s 343 
families; however, there was no significant association between the type of 344 
cooking fuels and outcomes (Table 2). 345 
Among the findings of physical examination, rales and chest indrawing 346 
were the most common signs in both age groups (Table 3). On admission, 19.1% 347 
(968/5054) of fatal patients had fever (>38.5°C), and fever was significantly 348 
more frequent in the deceased group than in the survived group of both age 349 
groups. Sensorial changes were present in 28.0% of the fatal cases; these changes 350 
were more frequent in the deceased group than the survived group of both age 351 
groups (p <0.001). Glasgow coma scale <9 was also associated with fatal 352 
outcome in children aged 2-59 months (p <0.001). The prevalence rate of 353 
hypoxemia was 13.0% (654/5023). Among the respiratory signs, grunting, 354 
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decreased breath sounds, central cyanosis, apnoeic episode and SpO2 <90% were 355 
more commonly observed in the deceased group than in the survived group of 356 
both age groups (Table 3). 357 
The proportion of patients with severe anaemia (<8g/dL) was higher in the 358 
deceased group of both age groups (p <0.01), while the mean hemoglobin level 359 
was lower only in the patients aged 2-59 months (10.3 vs 11.2 g/L, p <0.001). 360 
WBC counts were significantly higher in the deceased cases than in the survived 361 
cases in both age groups, while neutrophil cell count was higher in the deceased 362 
cases than in the survived cases in both age groups, but statistical significance 363 
was only observed in patients aged 2-59 months (9.86 vs 7.17 10
3/μL, p =0.01) 364 
(Table 3). 365 
A total of 4,498 children had chest radiographs; of these, 4,452 showed 366 
interpretable results. At least one abnormal finding was noted in 1,711 (38.4%) 367 
chest radiographs. Among the deceased cases, 41.6% patients showed end-point 368 
pneumonia, 5% had consolidation, 35% had infiltrations, and 3.4 % had pleural 369 
effusion These findings were significantly more common in the deceased cases 370 
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than in the survived cases except for pleural effusion in children aged <2 months 371 
age (Table 3).  372 
6 2 Pathogens detected  373 
6 2 1 Viruses detected from nasopharyngeal swabs  374 
 Of the 5,054 nasopharyngeal swabs, 61.0 % were tested positive for at least one 375 
virus. RSV was the most common viral pathogen, which was found in 27.0% 376 
(1352/5054), of which, 135(10.0%) of them had co-infection with other viruses. 377 
RV was the second most common viral pathogen, which was detected in 23.0% 378 
(1156/5054) of the cases, of which 173(17.6 %) had co-infection infections with 379 
other viruses. The RSV positive rate was significantly lower in the deceased 380 
cases among patients aged 2-59 months. A similar trend was also observed in 381 
patients aged <2 months; however, the difference was not statistically significant. 382 
The positive rates of RSV-A, RSV-B, and HMPV were also significantly lower 383 
in the cases than in the survived cases among those aged 2-59 months. On the 384 
other hand, the positive rate of ADV, specifically for ADV-7 was significantly 385 
higher in the deceased cases than in the survived cases for patients aged 2-59 386 
months, while the CFRs of ADV and ADV-7 were 10.7% and 24.0%, 387 
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respectively. The positive rate for EV-D68 was higher in the deceased cases than 388 
in the survived cases, although the difference was not statistically significant 389 
(Table 5 and 6). 390 
6 2 2 Bacteria detection in blood.  391 
 A total of 3,000 blood samples were tested for bacterial culture. The overall 392 
positivity rate for any pathogenic bacteria in the blood samples was 1.6% 393 
(49/3,000) and the CFR among blood culture-positive cases was 18.3% (9/49). 394 
The most commonly identified bacterial pathogen was B. cepacia (26.5%, n=13), 395 
followed by S. pneumoniae (22.4%, n=11), and A. baumannii (n=5) (Tables 5 396 
and 6). The positive rates for blood culture were significantly higher in the 397 
deceased cases than in the survived cases in both age groups. Among the 398 
deceased cases in the patients aged 2-59 months, the identified bacteria included 399 
P. aeruginosa (n=2), S. pneumoniae (n=2), MRSA (n=2), A. baumannii (n=1), B. 400 
cepacia (n=1), and K. pneumoniae (n=1) while A. baumannii and K. pneumoniae 401 
were identified in the deceased cases aged <2 months (Table 5 and 6). 402 
 403 
6 3 Factors associated with deaths  404 
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6 3 1 Univariate logistic regression analysis of factors associated with death 405 
 In the univariate analysis, the demographic, clinical and laboratory findings 406 
significantly associated with death in both age groups included severe 407 
underweight (weight-for-age <-3SD), presence of congenital abnormalities, 408 
decreased breath sounds, grunting, sensorial changes, central cyanosis, fever 409 
(>38.5°C), SpO2<90%, anaemia (<8g/dL), endpoint pneumonia and blood culture 410 
positive for bacteria (Tables 3 and 4). In addition, past experiences of child loss, 411 
tachypnea, and pleural effusion were associated with death in patients aged 2-59 412 
months. Infection with RSV [OR: 0.33(95%CI 0.2-0.52)], and HMPV [OR: 0.25 413 
(95%CI: 0.04-0.79)] were negatively associated with death in patients aged 2 -59 414 
months (Table 3 and 4). In contrast ADV [OR: 4.18(1.79-8.57)], particularly 415 
ADV-7 [OR: 10.66 (95%CI: 3.68-27.77)] was positively associated with death in 416 
children aged 2 -59 months (Tables 5 and 6). 417 
6 3 2 Multivariate logistic regression analysis of factors associated with 418 
death  419 
After adjusting for age in months, the year of sampling, and the hospital in the 420 
multivariate analysis, the following factors were found to be associated with 421 
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death in both age groups: severe underweight, presence of congenital 422 
abnormalities, decreased breath sounds, grunting, sensorial changes, central 423 
cyanosis, SpO2 (<90%,) fever (>38.5C), anaemia (<8 g/dL), consolidation, 424 
infiltration, blood culture positive for bacteria (Tables 3 and 4). Moreover, past 425 
experience of child loss, mild underweight (-3SD ≤ w<-2SD), tachypnea, 426 
tachycardia, ADV, ADV-7 and seasonal IFV A (H1N1) were found to be 427 
associated with death in children 2-59 months. In contrast, RSV, HMPV and RV-428 
C infections decreased the odds of death in children aged 2-59 months (Tables 4, 429 
5, 6). 430 
 431 
6 3 3 Multivariate logistic regression analysis of factors associated with 432 
deaths tested positive for different pathogens. 433 
 The factors with the deceased cases were analysed for those positive for RSV, 434 
RV, ADV, EV, blood culture for bacteria, and negative for all viruses (Table 7). 435 
The presence of fever >38.5°C increased the odds of death in patients infected 436 
with RV, ADV, EV, and bacteria and in patients who were tested negative for all 437 
viruses. The presence of hypoxemia increased the odds of death in patients 438 
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infected with RSV, RV and ADV. The presence of infiltration increased the odds 439 
of death in patients infected by RSV, ADV and EV. Interestingly, pleural 440 
effusion was associated with death in the group of patients who are negative to 441 
all viruses (Table 7). 442 
 443 
 7 Discussion  444 
The overall CFR of children hospitalised with severe pneumonia in the 445 
present study was 4.7%. This value is similar to those reported in other LMIC
35 54 
446 
55
. A significant decreasing trend of mortality was observed during the study 447 
period; however, this trend essentially reflected the trend of EVRMC, and could 448 
be attributed to the improved access to health-care facilities and the improved 449 
management of childhood pneumonia in the past decade. Another possible reason 450 
may be the introduction of new vaccines such as H. influenzae type b (Hib) 451 
vaccines and pneumococcal conjugate vaccines (PCV). These vaccines have been 452 
shown to reduce the mortality due to childhood pneumonia 
22 23
. However, in the 453 
Philippines, Hib vaccines were introduced in 2010 and PCVs were introduced in 454 
2014
56
. Vaccination coverage for Hib and PCV were estimated to be 67% and 455 
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35%, respectively in 2014 
56
. Since a decreasing trend in CFR was observed 456 
before the introduction of these vaccines, other factors such as improved access 457 
to health-care facilities and improved quality of care are more likely to have 458 
contributed to the reduction of CFR.  459 
Children aged <24 months accounted for 87.0% of total deaths, which is 460 
comparable with the global estimate of 81.0% of pneumonia-related deaths 461 
occurring in children aged < 2 years
57
. Patients aged 2-5 months showed the 462 
highest CFR of 7.0 %. Similar results have also been reported in a previous study 463 
conducted in the Philippines, wherein children of this age group were at risk for 464 
pneumonia-associated mortality
18
. The immune system of patients in this age 465 
group is not fully functional 
58
 and children aged 2-5 months have a lower level 466 
of circulating IgG in the blood than in other age groups
59
.  467 
Moreover, an association between the history of child loss in the family 468 
and deaths was found in children aged <2-59 months, which may be due to the 469 
lack of financial resources in the family, limited access to health-care facilities, 470 
or inappropriate health-seeking behaviour of the caretakers such as self-471 
medication, which may result in delayed commencement of proper care for 472 
children with pneumonia
60
. Another contributing factor can be the higher number 473 
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of children per family among families  in which the history of child loss was 474 
observed. In the present study, CFR was higher in families with the number of 475 
children ≥4, although it was not significant. The increased risk of pneumonia in 476 
households using solid cooking fuel and low SES has been well characterised in 477 
the past 
3 5-7
. However, their role in the fatal outcome of childhood pneumonia 478 
remains to be established in hospital settings.  479 
More than half of the patients (55.0%) who died were moderate or severe 480 
underweight (weight-for-age <-3SD). A similar rate of 52.5% has been reported 481 
among undernourished patients who died of infectious diseases in LMIC among 482 
children <5 years
61
. In a hospital-based study conducted in Malawi, the CFR-483 
attributed to pneumonia was high among patients with severe malnutrition, 484 
despite the general trend of decreasing CFR among patients with pneumonia
35
, 485 
which suggests that severely malnourished children with pneumonia require 486 
intensive inpatient care 
62
. Furthermore, malnutrition and HIV are endemically 487 
present in many areas in the world
63-65
. The underlying mechanisms explaining the 488 
association between infections and malnutrition are not well established. 489 
Deficiencies of some micronutrients have been found to be associated with some 490 
conditions. Vitamin D deficiency has been reported to increase the risk of RSV 491 
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infection 
66
, and zinc deficiency was found to be associated with acute respiratory 492 
diseases 
67
. Additionally, impairment of intracellular bacterial digestion 
68
, and an 493 
increase of risk of bacterial resistance to β-lactam by increasing exchange of ß-494 
lactamase encoding genes between bacteria, were reported among severely 495 
malnourished patients 
69
. Guidelines for the management of pneumonia in 496 
children with malnutrition should consider this strong association with mortality. 497 
 498 
Several clinical factors have been found to be associated with death including 499 
decreased breath sounds, grunting, severe anaemia, central cyanosis, and fever 500 
(>38.5°C), which are consistent with those reported previously 
35 37
. In children 501 
<2 months particular attention needs to be given to patients with fever > 38.5°C 502 
because of the high CFR of 32.5%. A bacterial infection should be considered in 503 
pneumonia cases with fever >38.5°C as reported elsewhere
70
. However, in 504 
malaria endemic areas, fever >38.5°C can be confused with malaria. Several 505 
other conditions can present similar clinical features, and patients can have 506 
multiple conditions simultaneously
11-14
. 507 
 508 
Hypoxemia (SpO2<90%) prevalence was 13.0% in this study, which is 509 
compatible to the mean rate of hypoxemia among severe and very severe 510 
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pneumonia cases in a review study
71
, but lower than the reported hypoxemic 511 
cases of 20% in Bohol Island in the Philippines 
72
. Some patients had received 512 
the oxygen supply before SpO2 measurement in this study, which might 513 
underestimate the prevalence of hypoxia. Hypoxemia was associated with death 514 
in this study, in concordance with earlier findings
73-77
. In a multicentre study that 515 
included five LMIC, the CFR among the hypoxemic patients was 8.5%
78
, which 516 
is lower than the range of CFRs (12.6%-15.7%) among the hypoxemic patients in 517 
this study. Hypoxemia was associated with viral infections such as RV and RSV 518 
and with poor outcome particularly in ADV infection
79-83
. In this study, 519 
hypoxemia was significantly associated with death in patients infected with RV, 520 
RSV and ADV, and adjusted OR was particularly high for ADV. Central 521 
cyanosis was also significantly associated with death for RSV and RV, which 522 
suggests that hypoxia, is particularly important in viral infections (Table 5). The 523 
use of pulse oximeter for detection of hypoxemia in the management of 524 
community-acquired pneumonia has been proven to be useful, and it is able to 525 
increase the referral of patients and reduce the rate of improper treatment with 526 
antibiotics 
84 85
.  527 
 528 
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The presence of a positive chest radiograph findings generally increase 529 
CFR. CFR among the cases with consolidation was 13.0%, which is the same as 530 
the reported mean CFR of 13% in a multicentre study on childhood pneumonia 
38
. 531 
The positivity rates for abnormal findings of chest radiograph varied across 532 
countries with the type of population and the presence of comorbidities
38
 but the 533 
association of endpoint pneumonia and consolidation with death or treatment 534 
failure have been consistently reported 
18 76 77
. In addition, patients positive for 535 
RV and bacteria and negative for any viruses were more likely to die if they had 536 
abnormal findings by chest radiograph. These findings suggest that among 537 
patients positive for RV and negative for any viruses, a subset of these patients 538 
may have bacterial pneumonia.  539 
 Seasonal IFV A (H1N1) had a CFR of 40% in children aged 2-59 months, which 540 
was in contrast with the CRF of 0% for IFV A (H1N1) pdm09. The reason why 541 
seasonal IFV A(H1N1) had such a high CFR remains unclear, however it should 542 
be noted that all seasonal IFV A(H1N1) occurred during the period of 2008 to 543 
2009, which was marked by an overall high CFR. ADV-7 had CFR of 24.0% in 544 
patients aged 2-59 months, which concurs with a similar finding in China
86
. Most 545 
cases of ADV-7 in this study occurred between 2008 and 2011, which coincided 546 
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with the ADV-7 outbreaks in China 
86 87
. CFR associated with EV-68 (8.5%) was 547 
also higher than the average value. The association of EV-68 with severe ALRI, 548 
including pneumonia, has been well reported across several studies, including 549 
those reporting fatal cases 
34 88-90
. RSV was the most common virus identified in 550 
the present study, which is in agreement with some previous reports 
31-33
. 551 
However, RSV was negatively associated with death. Similar findings were also 552 
observed in other studies conducted in hospital settings even in high-risk 553 
populations such as HIV positive patients and cases with comorbidities
91-94
.  554 
RV presented with the highest number of deaths in this study. In contrast 555 
to RSV, which was significantly and inversely associated with death in children 556 
aged 2−59 months, RV did not have any positive or negative associations with 557 
death. RV is classified into three species, RV-A, B and C. CFRs for RV-A and B 558 
were higher than average, but the difference was not statistically significant. The 559 
CFR of RV-C was lower in patients aged 2-59 months, which was statistically 560 
significant in the univariate analysis. Some studies revealed that RV-C is 561 
associated with severe respiratory infections, including deaths
95
. However, the 562 
data from this study does not support this association. As mentioned earlier, 563 
some RV positive cases, especially those positive for RV-A and B may include 564 
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bacterial pneumonia cases. Further studies are required to determine the 565 
association of different RVs with pneumonia and deaths due to pneumonia. I also 566 
did not observe an increase of the risk of death in patients with multiple viral 567 
infections, which is consistent with an earlier report
96
. However, the majority of 568 
multiple infections that occurred due to RV, RSV, and both of the viruses did not 569 
increase the risk of death. Additionally, it is also possible that some of these 570 
viruses were not the cause of symptoms as they can be found in asymptomatic 571 
patients 
97 98
. 572 
 573 
Blood culture positive for bacteria was associated with death as reported 574 
elsewhere 
99 100
. CFR among the patients positive for bacteria was 5 times higher 575 
than the overall CFR in children aged < 2 months old. 576 
 Methicillin-resistant Staphylococcus aureus was identified in 2 patients 577 
with fatal outcome. This bacterium is known to cause nosocomial infection
101
. 578 
Similarly for B. cepacia and A. baumannii can be identified as a result of 579 
nosocomial infection or environmental contamination
102-104
. Since blood samples 580 
were collected immediately after admission, the possibility of nosocomial 581 
transmission of these bacteria is low. However, a possibility of environmental 582 
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contamination cannot be ruled out. Furthermore, a study done among childhood 583 
pneumonia cases in the Philippines in Bohol Island did not report either B. 584 
cepacia nor A. baumannii suggesting a possibility of environmental 585 
contamination
105
.  586 
A proper diagnosis of bacterial infection and early treatment with 587 
antibiotics are particularly important in this group of patients. However, there 588 
were no specific signs and symptoms that could differentiate the patients with 589 
bacterial infections and those with viral infections. Furthermore, the detection 590 
rate of bacteria was low, which is similar to the findings of previously published 591 
reports
106 107
, particulary with those conducted in the Phillipines, which reported 592 
a positivity rate of 1.1% 
105
. The possibility of an antimicrobial treatment before 593 
admission in hospital may play a role in low positivity rate since the 4 hospitals 594 
in studies are all secondary of teriary referal centers.  595 
 Although the sensitivity of blood culture for childhood pneumonia is 596 
extremely low, there is no alternative to the gold standard in the diagnosis of 597 
bacterial pneumonia in children. The difficulty in obtaining proper sputum 598 
samples from children also prevented us from identifying the pathogens in 599 
patients 
108
.  600 
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The positive rate for at least one pathogen was 68% for all patients and 601 
54.4% for fatal cases. Although the availability of molecular diagnostic assays 602 
such as PCR has greatly increased the ability to detect respiratory viruses, 603 
detection of other pathogens remains a challenge in childhood pneumonia as 604 
observed in others studies 
109 110
.  605 
 606 
 This study has some limitations. IMCI algorithm was used as diagnosis 607 
criteria; however, these criteria are not able to distinguish pneumonia from other 608 
acute lower respiratory infections, such as bronchitis and bronchiolitis 
10 52
. 609 
Inclusion of the DAMA-deteriorated cases as deaths could have increased the 610 
CFR. Data collection on social factors started from 2014 onward, and limited 611 
analysis was possible for risk factors. And finally, some clinical and laboratory 612 
data were missing, especially in fatal cases because several deaths occurred 613 
immediately after hospital admission. Similarly, the sampling rate for blood 614 
culture was lower for fatal cases because the patients died before their samples 615 
could be obtained. Despite these limitations, this study had a large sample size of 616 
more than 5,000 patients and studies over a long duration of 9 years in a lower-617 
middle income country, which provided a comprehensive data on the 618 
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demographics, clinical characteristics, mortality and aetiology of hospitalised 619 
children with severe pneumonia in the Philippines that can be generalised not 620 
only in the Philippines but also in other LMICs with high level of malnutrition. 621 
However, in areas with high HIV-AIDS prevalence, the possibility of 622 
Pneumocystis jiroveci 
111
 and other opportunistic infections should be considered.  623 
8 Conclusion 624 
Underweight (malnutrition) remains the most common factor associated with 625 
death among childhood pneumonia cases. Therefore, reinforcing measures to 626 
improve nutritional status will probably reduce the mortality rate of childhood 627 
pneumonia. SpO2<90% was also an important predictor for fatal outcome. 628 
Monitoring of oxygen saturation should be promoted not only in severe but also 629 
in non-severe childhood-pneumonia cases and supplementary oxygen therapy 630 
should be administered in these patients. Due to the association of chest 631 
radiograph findings with death, a chest radiograph should be required in all 632 
hospitalised patients with signs of pneumonia and health workers should be 633 
trained to read the chest radiograph. The adequate measure should be taken to 634 
diagnose or eliminate the presence of bacterial infections. Continuous detection 635 
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of EV-D68 and ADV-7 infections should be performed for monitoring and 636 
control of future outbreaks.  637 
 638 
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 970 
Figure1. Map depicting the location of study sites participating in the childhood pneumonia 971 
study in the Philippines, 2008-2016. A dot indicates hospital location and the color refers to 972 
hospital name. hospital coordinates were recorded by using google maps and mapped the 973 
geographical distribution of hospital with ArcGIS 10.4 (ESRI, Redlands, CA, USA). This study 974 
used the administrative boundaries of The Philippines from the PhilGIS website 975 
(http://philgis.org/ and then we overlaid the administrative boundaries layer with openstreetmap 976 
tool in ArcGIS 10.4 (ESRI, Redlands, CA, USA)). 977 
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Figure 2 : Duration of study by hospitals participating in the childhood 982 
pneumonia study in the Philippines, 2008-2016. 983 
Note: BPH, Biliran Provincial Hospital ; EVRMC, Eastern Visayas Regional 984 
Medical Center; ONP, Ospital NG Palawan, Eastern Visayas Regional Medical 985 
Center (EVRMC); RITM, Research Institute for Tropical Medicine 986 
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Figure 3: Flowchart of study participants in the childhood pneumonia study 1004 
in Philippines, 2008-2016.  1005 
Loss to follow up, unknown 
outcome, transferred to 
another hospital (n=74) 
Were included in analysis  
1112 (22%) patients in sociodemographic and economic status study 
5054 patients with medical records  
4336(85.8%) measurement of saturation of oxygen 
5054 nasopharyngeal result tested for different viruses  
4452 (88 %) of chest radiographs 
3018 (60%) of blood culture for identification of bacteria done (49 bacteria were diagnosed) 
 
 
Children <2month 
Survived (n: 709) made of 
 Survived observed in hospital (n: 605)  
 DAMA improved (n: 104) 
Fatal outcomes (n: 40) made of: 
 Deaths observed in hospital (n= 28) 
 And DAMA Deteriorated (n=12).  
 
 
Study period: 2008-2016 
Enrolled patients 
Severe and very severe pneumonia cases 
(N= 5128) 
 
 
 
Children 2-59 months 
Survived: (n: 4107) made of 
 Survived observed in hospital (n: 3722) 
 DAMA improved (n: 385) 
Fatal outcomes (n: 198), made of: 
 Deaths observed in hospital (n= 165) 
 And DAMA Deteriorated (n=33).  
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Table 1 Yearly Distribution of Children Hospitalised with Severe Pneumonia Stratified by Hospital and Outcomes 
Year BPH EVRMC ONP RITM 
All 
Hospitals 
 
Survived 
(n) 
 Deceased (n) CFR (%) 
Survived 
(n) 
 Deceased (n) CFR
δ
 (%) 
Survived 
(n) 
 
deceased 
(n) 
CFR (%) 
Survived 
(n) 
 Deceased (n) 
CFR 
(%) 
CFR* 
(%) 
2008 - - - 482 69 12.5 - - - - - - 12.5 
2009 - - - 297 23 7.2 - - - - - - 7.2 
2010 - - - 292 23 7.3 - - - - - - 7.3 
2011 - - - 640 24 3.6 - - - - - - 3.6 
2012 62 5 7.5 395 22 5.3 159 5 3.0 18 0 0.0 4.8 
2013 327 7 2.1 345 4 1.1 387 6 1.5 94 6 6.0 2.0 
2014 301 4 1.3 335 14 4.0 245 8 3.2 82 4 4.7 3.0 
2015 274 10 3.5 23 1 4.2 9 0 0 3 0 0.0 3.4 
2016 46 3 6.1 - - - - - - - - - 6.1 
Total: 1010 29 2.8 2809 180 6.0 800 19 2.3 197 10 4.8 4.7 
 
Note: BPH, Biliran Provincial Hospital; EVRMC, Eastern Visayas Regional Medical Center; ONP, Ospital Ng Palawan; RITM, Research Institute 
for Tropical Medicine; CFR, case fatality rate. (*), decreasing trend of CFR from 2008 to 2009 was statically significant p < 0.05 for all patients 
but also for those for only EVRMC patients (δ) 
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Table 2. Demographic, Socio-economic and Environmental Characteristics of Children Hospitalised 
with Severe Pneumonia, Stratified by Age Group and Outcome. 
 
 
Children <2 months 
 
Children 2−59 months 
 Survived  Deceased  CFR p-value Survived  Deceased  CRF p-value 
 n=709 n=40 5.3  n=4107 n=198 4.6  
Age group          
 Less than 1 month  286 (40.3) 17 (42.5) 5.6 0.86    <0.001 
 1 month  423 (59.7) 23 (57.5) 5.2      
 2-5 months      1011 (25.2) 76 (38.4) 7.0  
 6-11months     
 
1064 (25.9) 50 (25.3) 4.5  
 12-35 months     
 
1677 (40.8)  59 (29.8) 3.4  
 36-59 months     
 
355 (8.6) 13 (6.7) 3.5 
 Gender         
 Female 285 (40.2) 17 (42.5) 5.6 0.90 1786 (43.5) 90(45.5) 4.8 0.49 
 Male 424 (59.8) 23 (57.5) 5.1  2321 (56.5) 108 (54.5) 4.5  
Hospital admitted 
  
 0.003 
  
 
  BPH 215 (30.3) 3 (7.5) 1.4 <0.001 795 (19.4) 26 (13.1) 3.2 <0.001 
 EVRMC 380 (53.6) 32 (80.0) 7.8 
 
2429 (59.1) 148 (74.7) 5.7  
 ONP 88 (12.4) 4 (10.0) 4.3 
 
712 (17.3) 15 (7.6) 2.1  
 RITM 26 (3.7) 1 (2.5) 3.7 
 
171 (4.2) 9 (4.6) 5.0 
 Congenital abnormalities         
 Yes 8 (1.1) 3 (2.5) 27.3 0.01 33 (2.6) 9 (3.5) 6.2 <0.001 
 No 691 (98.9) 37 (92.5)   4035 (99.2) 187 (95.4)   
 Missing  10 0   39 2   
Height(h)-for-age 
  
 
   
 
  -2SD ≤ h≤2SD 251 (59.1) 5 (45.5) 2.0 0.35 1213 (53.9) 33 (48.5) 2.6 0.32 
 -3SD ≤ h<-2SD 63 (14.8) 1 (9.1) 1.6  397 (17.6) 10(14.7) 2.5  
 h<-3SD 111 (26.1) 5 (45.5) 4.3  642 (28.5) 25(36.8) 3.7  
 Missing  284 29   1855 130   
Weight(w)-for-age 
  
 
   
 
  -2SD ≤ w≤2SD 511 (78.7) 15 (44.1) 2.9 <0.001 2424 (61.2) 82 (43.3) 3.3 <0.001 
 -3SD ≤ w<-2SD 86 (13.3) 5 (14.7) 5.5  764 (19.3) 36 (18.6) 4.5  
 w<-3SD 52 (8) 14 (41.2) 21.2  776 (19.6) 76 (39.2) 8.9  
 Missing 61 6   143 6   
Duration of hospitalization 8 [6‒9] 3.5 [1‒8.2]  <0.001 4 [3‒6] 1 [1‒3]  <0.001 
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Table 2 (continued): Demographic, Socio-economic and Environmental Characteristics of Children 
Hospitalised with Severe Pneumonia, Stratified by Age Group and Outcome 
 Children <2 months 
 
Children 2−59 months 
 Survived  Deceased  CFR p-value Survived  Deceased  CRF p-value 
 n=184 n=4   n=904 n=23   
SES         
 ≤30 83 (46.1) 3 (75) 3.5 0.560 504 (55.8) 15 (65.2) 2.9 0.490 
 >30 97 (53.9) 1 (25) 1.0  400 (44.2) 8 (34.4) 2.0  
 Missing 5  1   0 0   
Past experience of child 
loss 
        
 Yes 15 (11.4) 0(0.0) 0.0 1.000 71 (10.2) 7 (33.3) 9.0 0.003 
 No 117 (88.6) 2 (5.0) 1.7  626 (15.2) 14 (4.0) 2.2  
 Missing 53 3   207 2   
Number of siblings         
 <2 55 (29.7) 2 (50) 3.5 0.420 199 (22.1) 3 (13.5) 1.5 0.055 
 2‒3 78 (42.2) 2 (50) 2.5  441 (48.9) 8 (34.8) 1.8  
 ≥4 52 (28.1) 0 0.0  262 (29) 12 (52.2) 4.4  
 Missing 0 1   2 0   
Types of 
cooking fuel 
used  
        
 Electricity,  
petroleum gas, and 
Kerosene 
26 (14.1) 0 0.0 0.100 121 (12.8) 2 (8.7) 1.7 0.780 
 Charcoal, and Wood 158 (85.9) 4 (100) 2.5  775 (86.5) 21 (91.3) 2.6  
 Missing  1 1   8 23   
 
 
NOTE: n (%), number and percent of child unless stated otherwise. CFR, case fatality rate (%); duration 
of hospitalization is presented as median with IQR, interquartile range; h, height; w, weight; congenital 
abnormalities including Down syndrome and congenital heart disease; SES, socio-economic status; 
BPH, Biliran Provincial Hospital; EVRMC, Eastern Visayas Regional Medical Center; ONP, Ospital Ng 
Palawan. (*)Analysis from February 2014 to March 2016 
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Table 3. Clinical and Laboratory Findings of Children Hospitalised with Severe Pneumonia, Stratified 
by Age Group and Outcome 
 Children < 2 months 
 
Children-2−59 months 
 Survived  Deceased  CFR p-value Survived  Deceased  CFR p-value 
Clinical findings n=709 n=40 5.3  n=4107 n=198 4.6  
Neck rigidity         
 Yes 2 (0.4) 0(0.0) 0.0 1.000 6 (0.1) 2 ( 2.7) 25.0 0.008 
 No 457 (99.6) 12 (100)   2433 (99.8) 71 (97.3)   
 Missing 250 28   1668 125   
Sensorial changes         
 Yes 26 (3.7) 10 (25.0) 27.8 <0.001 146 (4.0) 51 (28.8) 25.9 <0.001 
 No 608 (95.9) 28 (73.7)   3466 (96) 126 (71.2)   
 Missing 75 2   495 21   
Glasgow coma scale          
 Severe 1 (14.3) 1 (50.0) 50.0 0.140 2 (3.6) 5 (62.5) 71.4 <0.001 
 Moderate 6 (85.7) 1(50)   54 (96.4) 4 (50)   
 Missing  702 38   4051 31   
Grunting         
 Yes 4 (0.9) 2 (18.2) 33.3 <0.001 13 (0.5) 6 (8.2) 31.6 <0.001 
 No 455 (99.1) 9(81.8)   2427 (99.5) 67 (91.8)   
 Missing 250 29   1667 125   
Decreased breath sounds          
 Yes 15 (2.1) 4 (10.0) 21.1 0.010 81 (2.0) 12 (6.1) 12.9 <0.001 
 No 694 (97.9) 36 (90.0)   4022 (98.0) 186 (93.9)   
 Missing 0 0   4 0   
         
Wheezing         
 Yes 91 (12.8) 9 (22.5) 9.0 0.130 1454 (35.4) 84 (42.4) 5.5 0.040 
 No 618 (87.2) 31(77.5)   2650 (64.6) 113 (57.4)   
 Missing 0 0   0 1   
Chest indrawing         
 Yes  704 (99.3) 38 (95) 5.1 0.050 4080 (99.4) 196 (99.0) 4.6 0.730 
 No 5 (0.7) 2 (5)   23 (0.6) 2 (1)   
 Missing  0 0   4 0   
Rales         
 Yes 693 (97.7) 39 (97.5) 5.3 1.000 4083 (99.5) 197 (99.5) 4.6 1.000 
 No 16 (2.3) 1(2.5)   21 (0.5) 1 (0.5)   
 Missing 0 0   3 1   
Central cyanosis         
 Yes 22 (3.1) 8 (20.0) 26.7 <0.001 45 (1.1) 47 (23.9) 51.1 <0.001 
 No 687 (96.9) 32 (80)   4056 (98.9) 150 (76.1)   
 Missing 0 0   6 1   
Apnoeic episode         
 Yes 3 (0.4) 3 (7.5) 50.0 <0.001 2 (0.04) 14 (7.1) 87.5 <0.001 
 No 706 (99.6) 37 (92.5)   4098 (99.06) 183 (92.9)   
 Missing 0 0   7 1   
Nasal flaring         
 Yes 183 (39.9) 8 (66.1) 4.2 0.110 996 (40.8) 39 (53.4) 3.8 0.040 
 No 276 (60.1) 4 (33.3)   1444 (59.2) 34 (46.6)   
 Missing 250 28   1667 125   
Tachypnea         
 Yes 594 (84.4) 35 (92.1) 5.6 0.250  3428 (83.8) 169 (91.4) 4.7 <0.001 
 No 110 (15.6) 3 (7.9)   663 (16.2) 16 (8.6)   
 Missing 5 2   16 13   
         
SpO2<90%         
 Yes 75 (10.7) 14 (35.0) 15.7 <0.001 494 (12.1) 71 (36.0) 12.6 0.005 
 No 629 (89.3) 26 (65.0)   3588 (87.9) 126 (64.0)   
 Missing 5 0   25 1   
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Table 3 (continued): Clinical and Laboratory Findings of Children Hospitalised with Severe Pneumonia, 
Stratified by Age Group and Outcome. 
 Children < 2 months 
 
 
Children-2−59 months 
Clinical findings Survived  Deceased  CFR p-value Survived  Deceased  CFR p-value 
 n=709 n=40 5.3  n=4107 n=198 4.6  
Tachycardia         
 Yes 61 ( 8.7) 4 ( 10.3) 6.2 0.770 1373 (33.8) 69 (35.6) 4.8 0.640 
 No 640 (91.3) 35 (89.7)   2691 (66.2) 125 (64.4)   
 Missing 6 1   43 5   
Fever >38.5 °C         
 Yes 23 (3.3) 11 (27.5) 32.4 <0.001 862 (21.0) 72 (36.1) 7.7 <0.001 
 No 686 (96.8) 29 (72.5)   3245 (79.0) 126 (63.6)   
 Missing 0 0   0 0   
         
Chest Radiographs 
 findings 
        
End-point pneumonia         
 Yes 40 (5.6) 11 (27.5) 15.5 <0.001 1155 (31.3) 81 (50.9) 6.6 <0.001 
 No 669 (94.4) 29 (72.5)   2493 (68.3) 72 (47.1)   
 Missing 0 0   548 45   
Consolidations         
 Yes 40 (6.5) 11 (31.4) 21.6 <0.001 366 (9.9) 49 (32) 11.8 <0.001 
 No 572 (93.5) 24 (68.6)   3286 (90.1) 104 (68)   
 Missing  97 5   455 45   
Infiltrations         
 Yes 120 (19.4) 13 (37.1) 9.8 0.020 1301 (35.3) 70 (44.0) 5.1 0.010 
 No 493 (80.4) 22 (62.9)   2351 (64.4) 83 (54.2)   
 Missing  96 5   455 45   
Pleural effusions         
 Yes 1 (0.2) 1 (2.9) 50.0 0.100 25 (0.7) 7 (4.4) 21.9 <0.001 
 No 612 (99.8) 34 (97.1)   3630 (99.3) 146 (95.4)   
 Missing  93 5   452 45   
Chest X-ray         
 Negative 473 (77.3) 14 (40) 2.9 <0.001 2159 (59.2) 58 (37.9) 2.6 0.001 
 Positive 139 (22.7) 21 (60) 13.1  1490 (40.8) 95 (62.1) 6.0  
 Missing 97 5   458 45   
         
Complete Blood  
Counts Results 
 
        
Haematocrit (%) 36.0 [7.7] 38.0 [7.8]  0.430 34.0 [4.6] 31.0 [5.9]  <0.001 
Haemoglobin (g/dL)  12.0 [2.5] 12.3 [2.7]  0.400 11.2 [1.5] 10.3 [1.9]  <0.001 
WBC count (103/μL)  11.1 [6.5] 15.3 [14.6]  0.040 12.2 [6.2] 13.1 [11.2]  0.004 
Neutrophils (103/μL)  4.4 [2.7] 10.3 [9.1]  0.060 7.17 [4.9] 9.86 [8.8]  0.010 
Platelets (109/μL) 358 [140] 280 [141]  0.080 362 [160] 365 [196]  0.850 
Severe anaemia <8g/dL         
 Yes 4 (0.6) 2 (5.6) 33.3 <0.010 93 (2.4) 18 (9.7) 16.2 <0.001 
 No 666 (99.4) 34 (94.4)   3810 (97.6) 168 (90.3)   
 Missing 39 4   204 12   
 
Note: n (%), number and percent of children unless stated otherwise; Rate of each parameter was 
calculated without the missing values. CFR, case fatality rate (%); In complete blood counts results, 
mean [SD] were presented; SpO2, saturation of peripheral oxygen; WBC, white blood cells; SD, 
standard deviation in each standardised units; Anaemia was defined when haemoglobin was <8 g/L. 
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Table 4 Factors Associated With Death Among Children Hospitalised With Severe Pneumonia, 
Stratified By Age Group. 
 
Children <2 months Children -2−59 months 
 Factors  
Crude OR 
(95% C.I.) 
Adjusted OR 
(95% C.I.) 
Crude OR 
(95% C.I.) 
Adjusted OR 
(95% C.I.) 
Age group     
 Less than 1 month  Ref. Ref. - - 
 1 month  0.93 (0.6-1.5) 0.9 (0.57-1.44) - - 
 2 - 5 months  - - 1.73 (1.17-2.69) 1.77 (1.19-2.75) 
 6-11months  - - 1.29 (0.89-1.82) 1.29 (0.89-1.82) 
 12-35 months  - - 0.97 (0.72-1.3) 0.96 (0.72-1.29) 
 36-59 months - - Ref Ref 
Past experience of child loss NA NA 4.9 (1.83-11.87) 5.42 (1.99-13.51) 
Weight(w)-for-age     
 -2SD ≤ w≤2SD Ref. Ref. Ref Ref 
 -3SD ≤ w<-2SD 1.98 (0.63-5.25) 1.98 (0.62-5.33) 1.41 (0.93-2.1) 1.58 (1.04-2.35) 
 w<-3SD 9.15 (4.15-20.12) 9.59 (4.22-21.88) 2.93 (2.12-4.05) 3.22 (2.3-4.51) 
Presence of  
congenital abnormalities 
7.0(1.49-25.35) 1.96 (0.08-2.43) 5.88 (2.62-11.97) 3.12 (1.08-8.62) 
Decreased breath sounds 5.14 (1.41-15.03) 9.81 (2.11-46.49) 3.2 (1.64-5.76) 5.36 (2.6-10.38) 
Grunting 25.28 (3.22-148.64) 28.65 (2.89-259.6) 16.72 (5.73-43.71) 14.27 (4.64-39.86) 
Sensorial changes 1.59 (1.01-3.3) 1.79 (1.13-3.22) 9.61 (6.63-13.78) 8.31 (5.68-12.0) 
Glasgow coma scale<9 6.0 (0.15-321.95) - 45.0 (6.92-437.72) - 
Central cyanosis 7.81 (3.07-18.33) 6.49 (2.50-15.63) 28.24 (18.19-43.95) 27.58 (17.55-43.5) 
Tachypnea 1.20 (0.35-3.13) 2.03 (0.7-8.6) 2.04 (1.25-3.57) 1.89 (1.15-3.34) 
Tachycardia 2.16 (0.76-9.07) 2.03 (0.56-5.84) 1.08 (0.8-1.46) 2.09 (1.42-3.07) 
SpO2<90% 4.52 (2.21-8.91) 4.69 (2.23-9.56) 4.09 (3.0-5.54) 5.06 (3.67-6.94) 
Wheeze 1.97 (0.86-4.12) 2.87 (1.11-6.87) 1.35 (1.01-1.81) 1.55 (1.15-2.08) 
Fever (>38.5 °C) 11.31 (4.9-25.07) 11.98 (5.03-27.87) 2.15 (1.59-2.89) 2.5(1.83-3.38) 
 Severe anaemia (<8 g/dL) 9.79 (1.32-52.0) 9.18 (1.18-54.0) 4.39 (2.51-7.27) 4.04 (2.29-6.8) 
Endpoint pneumonia 5.55 (2.76-11.24) 5.64 (2.74-11.68) 2.43 (1.75-3.36) 2.67 (1.92-3.73) 
Consolidation  6.55 (2.91-14.08) 5.37 (2.34-11.77) 4.23 (2.94-6.0) 4.11 (2.84-5.88) 
Infiltration  2.43 (1.16-4.9) 2.70 (1.26-5.57) 1.52 (1.1-2.11) 1.71 (1.23-2.38) 
Pleural effusion 18.0 (0.7-461.79) 23.0 (0.76-949.37) 6.96 (2.74-15.54) 6.85 (2.66-15.63) 
 
Note: SpO2, saturation of peripheral oxygen; OR, odds ratio; CI, confidence interval.  
Multivariate logistic models were adjusted by age in month, year of sampling and hospitals. 
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Table 5 Detected Pathogens And Clinical Outcome In Children <2 Months Old Hospitalised With 
Pneumonia, Philippines, 2008-2016. 
Pathogens 
 
Children <2 months 
 
  Survived  Deceased  p-value CFR OR AOR 
  (%) (%) 
 
(%) (95% C.I.) (95% C.I.) 
  (n=709) (n=40) 
    
RSV 190 (26.9) 6 (15)  0.070 3.1 0.48(0.18-1.08) 0.47(0.17-1.07) 
 RSV-A 105(14.9) 5(12.5) 0.860 4.5 0.82(0.28-1.96) 0.62(0.2-1.53) 
 RSV-B 69(9.8) 1(2.5) 0.210 1.4 0.24(0.01-1.12) 0.35(0.02-1.69) 
 Untyped RSV 16 0 
    
Influenza virus 8 (1.1) 0 (0) 1.000 0.0 - - 
 IFV A 5(0.7) 0(0) 1.000 0.0 - - 
 IFV A(H1N1) seasonal 1(0.1) 0(0) 1.000 0.0 - - 
 IFV A (H1N1)pdm09 - - - - - - 
 IFV A(H3N2) 2(0.3) 0(0) 1.000 0.0 - 
 
 Influenza B 3(0.4) 0(0) 1.000 0.0 - - 
 Untyped influenza 0 0 
    
RV 167 (23.6) 4 (10) 0.070 2.3 0.36(0.11-0.91) 0.35(0.1-0.89) 
 RV-A 73(10.3) 2(5) 0.410 2.7 0.46(0.07-1.53) 0.33(0.05-1.11) 
 RV-B 15(2.1) 0(0) 0.720 0.0 - - 
 RV-C 52(7.4) 2(5) 0.800 3.7 0.66(0.11-2.25) 0.71(0.11-2.5) 
 Untyped RV 27 - 
    
Enterovirus 10 (1.4) 1(2.5) 0.490 9.1 1.79(0.1-9.69) 2.85(0.15-18.22) 
 EV-D68 4(0.6) 1(2.5) 0.640 20.0 4.51(0.23-31.37) 5.07(0.23-45.75) 
ADV  3 (0.4) 0 (0) 1.000 0.0 - - 
 ADV-7 1 (0.1) 0 (0) 1.000 0.0 - - 
HMPV 8 (1.1) 2 (5) 0.170 20.0 4.6(0.68-19.14) 6.03(0.83-29.1) 
PIV 13 (1.8) 1(2.5) 1.000 7.1 1.37(0.07-7.15) 1.67(0.09-9.69) 
 
Multiple infections  
(Virus-virus ) 
37 (5.2) 2 (5.0) 1.000 5.1 0.95(0.15-3.28) 0.87(0.14-3.18) 
Negative for viruses 271 (38.5) 24 (60.0) 0.007 8.1 2.41(1.27-4.71) 2.5(1.29-4.99) 
Missing cases for testing  2 0     
Bacteria sample Tested n=447 n=11 
    
Bacteria  5 (1.1) 2 (18.2) 0,010 28.5 19.64 (2.58-106.01) 7.83 (6.39-110.45) 
Negative for  
all pathogens  163 (36.5) 5 (45.1) 0.810 2.9 0.75 (0.2-1.7) 0.75 (0.24-1.91) 
Virus-bacteria 
 co-detection 2(0.4) 0 (0) 1.000 0.0   
 
Note: n (%), number and percent of children. RSV, respiratory syncytial virus; RV, rhinovirus; EV-D68, 
enterovirus D68; ADV, adenovirus; ADV-7, adenovirus 7; HMPV, human metapneumovirus; PIV, 
parainfluenza virus; OR, odds ratio; CI, confidence interval; AOR, adjusted odds ratio. Multivariate 
logistic models were adjusted by age in week, year of sampling and hospitals. 
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Table 6 Detected Pathogens and Clinical Outcome In Children 2−59 Months Old Hospitalised With 
Pneumonia, Philippines, 2008-2016 
  
Children 2−59 months 
 
 Survived (%)  Deceased  p-value CFR OR AOR 
 
 
(%) 
 
(%) (95% C.I.) (95% C.I.) 
 (n=4107) (n=198) 
    
RSV 1002 (24.4) 19 (9.6) <0.001 1.9 0.33(0.2-0.52) 0.31(0.19-0.5) 
 RSV-A 576(14) 10(5.1) <0.001 1.7 0.33(0.16-0.59) 0.28(0.13-0.5) 
 RSV-B 365(8.9) 6(3) 0.006 1.6 0.32(0.13-0.67) 0.37(0.14-0.78) 
 Untyped RSV 61 3 
    
Influenza virus 154 (3.7) 9 (4.5) 0.700 5.5 1.22(0.57-2.3) 1.58(0.73-3.01) 
IFV-A 96(2.3) 6(3) 0.690 5.9 1.31(0.5-2.77) 1.63(0.62-3.53) 
 IFV A(H1N1) seasonal 6(0.1) 4(2) <0.001 40.0 14.09(3.58-49.74) 6.79(1.68-24.73) 
 IFV A (H1N1)pdm09 25(0.6) 0(0) 0.534 0.0 - - 
 IFV A(H3N2) 54(1.3) 2(1) 0.961 3.6 0.77(0.12-2.48) 1.39(0.22-4.6) 
 IFV B 52(1.3) 3(1.5) 1.000 5.5 1.2(0.29-3.29) 1.62(0.39-4.55) 
 Untyped influenza 0 0 
    
RV 774 (18.8) 38 (19.2) 0.970 4.7 1.02(0.7-1.45) 0.99(0.68-1.41) 
 RV-A 279(6.8) 20(10.1) 0.100 6.7 1.54(0.93-2.43) 1.3(0.78-2.08) 
 RV-B 34(0.8) 5(2.5) 0.038 12.8 3.1(1.05-7.34) 2.04(0.68-5) 
 RV-C 383(9.3) 10(5.1) 0.056 2.5 0.52(0.25-0.93) 0.57(0.28-1.03) 
 Untyped RV 78 
   
- 
 
Enterovirus 60 (1.5) 3 (1.5) 1.000 4.8 1.04(0.25-2.83) 1.18(0.28-3.29) 
 EV-D68 39(0.9) 3(1.5) 0.674 7.1 1.60(0.38-4.47) 1.67(0.4-4.8) 
ADV  41 (1) 8 (4) <0.001 16.3 4.18(1.79-8.57) 3.95(1.65-8.37) 
 ADV-7 19(0.5) 6 (3) 0.020 24.0 10.66(3.68-27.77) 11.44(3.77-31.38) 
HMPV 161 (3.9) 2 (1) 0.050 1.1 0.25(0.04-0.79) 0.3(0.05-0.95) 
PIV 110 (2.7) 6 (3) 0.940 5.2 1.14(0.44-2.4) 1.54(0.59-3.33) 
 
Multiple 
 infections (Virus-virus ) 
178 (4.3) 7 (3.5) 0.710 3.8 0.81(0.34-1.62) 0.71(0.3-1.44) 
Negative for viruses 1627(38.1) 106 (52.3) <0.001 6.1 1.14(0.44-2.4) 1.73(1.29-2.32) 
Bacteria sample Tested n=2465 n=77 
    
Bacteria  35(1.4) 7 (9) <0.001 16.7 7.02 (2.78-15.49) 5.08(1.8-12.78) 
Negative for  
all pathogens  756 (30.7) 36 (46.7) 0.300 4.5 0.75 (0.24-1.91) 0.75 (0.24-1.91) 
Virus-bacteria  
co-detection 17(0.7) 3 (3.9) 0.130 15.0   
 
Note: n (%), number and percent of children. RSV, respiratory syncytial virus; RV, rhinovirus; EV-D68, 
enterovirus D68; ADV, adenovirus; ADV-7, adenovirus 7; HMPV, human metapneumovirus; PIV, 
parainfluenza virus; OR, odds ratio; CI, confidence interval; AOR, adjusted odds ratio. Multivariate 
logistic models were adjusted by age in week, year of sampling and hospitals. 
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Table 7 Clinical Signs And Symptoms Associated With Death Among Children <59 Months Old Hospitalised With Pneumonia Who Were 
Tested Positive For Different Pathogens, Philippines, 2008-2016. 
Factors 
RSV 
AOR (95% C.I.) 
RV 
AOR (95% C.I.) 
ADV 
AOR (95% C.I.) 
EV 
AOR (95% C.I.) 
Bacteria 
AOR (95% C.I.) 
Negative for viruses 
AOR (95% C.I.) 
Grunting 1.00 (0.71-1.43) 0.91(0.63-1.32) - 2.79( 1.81- 4.31) 0.91 (0.47-1.79) 4.36 (1.91-9.98) 
Sensorial changes 2.11 (1.74-2.57) 1.19 (0.92-1.53) 1.09 (0.87-1.35) 1.46 (1.13 -1.89) 2.11 (1.41-3.17) 0.78 (0.69-0.87) 
Central cyanosis 1.21 (1.02-1.45) 1.62 (1.2-2.19) 1.25 (0.84 - 1.88) 1.27(0.91- 1.76) 1.61 (0.66-3.91) 0.81 (0.61-1.08) 
Alar flaring 1.04 (0.98-1.11) 1.01 (0.91-1.13) 0.99 (0.79 -1.25) 1.79(0.96- 3.33) 1.1 (0.7-1.73) 1.07 (0.94-1.23) 
Decreased breath sound 0.90 (0.71-1.15) 1.46 (0.97-2.2) 0.87 (0.54-1.40) 0.94(0.67- 1.33) 0.68 (0.29-1.61) 1.57(1.05-2.35) 
Wheezing 0.99 (0.89-1.10) 1.12 (0.96-1.3) 1.01 (0.84- 1.19) 8.27(2.83-24.15) 1.04 (0.79-1.39) 1.18 (0.98-1.42) 
Fever (>38.5 °C) 1.16 (0.96-1.4) 1.95 (1.51-2.51) 6.30 (1.57-25.21) 7.07(2.44- 20.48) 9.48 (1.91-47.0) 1.57 (1.22-2.03) 
Tachypnea 0.99 (0.88-1.1) 1.04 (0.91-1.2) - - 7.4 (1.06-51.67) 1.01(0.85-1.18) 
Tachycardia 1.16 (1.02-1.33) 1.07 (0.89-1.28) 1.41 (0.30 -6.48) 2.55( 1.10-5.89) 0.1 (0.01-0.81) 0.82 (0.65-1.02) 
SpO2<90% 1.27 (1.14-1.4) 1.29 (1.07-1.54) 6.17 (1.49 -25.42) 1.12 ( 0.93- 1.34) 1.17 (0.79-1.75) 0.95 (0.78-1.14) 
 Severe anaemia (<8 g/dL) 0.86 (0.48-1.51) 0.68 (0.38-1.2) - - 2.58 (1.51-4.4) 5.71 (2.92-11.17) 
Consolidation  1.02 (0.9-1.16) 1.13 (0.94-1.37) 6.69 (2.11-21.22) 1.53( 1.29- 1.82) 0.97 (0.69-1.35) 2.2 (1.69-2.88) 
Infiltration  1.13 (1.03-1.23) 1.07 (0.92-1.24) 6.22 (1.98-19.51) 1.17(1.03- 1.34) 7.84 (1.4-44.0) 1.13 (0.98-1.32) 
Pleural effusion - 1.33 (1.18-1.51) 0.93 (0.57- 1.50) 0.97(0.56-1.71) 1.05(0.59-1.84) 2.05 (1.07-3.95) 
 
Note: RSV, respiratory syncytial virus; RV, rhinovirus; ADV, adenovirus; EV, enterovirus, OR, odds ratio; CI, confidence interval. Multivariate 
logistic models were matched with age groups and adjusted by patients age, year of sampling and hospitals 
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Table 8: Demographic Characteristics Of Children Hospitalised With Severe 
Pneumonia, Stratified By Age Group And Outcome Excluding Children Who 
Were Discharged Against Medical Advice 
 
 
Children <2 months 
 
Children 2−59 months 
 Survived  Deceased  CFR p-value Survived  Deceased  CRF p-value 
 n= 605 n=28 4.4  n=3722 n=165 4.2  
Age group          
 Less than 1 month  239 ( 39.5)  15 ( 53.6)  5.9 
 
- -  <0.001 
 1 month  366 ( 60.5)  13 ( 46.4)  3.4  - -   
 2-5 months  - - -   903 (24.3)   68 (41.2)  7  
 6-11months  - - - 
 
 964 (25.9)   43 (26.1)  4.3  
 12-35 months  - - - 
 
1530 (41.1)   45 (27.3)  2.9  
 36-59 months  - - - 
 
 325 ( 8.7)   9 ( 5.5)  2.7 
 Gender         
 Female 361 ( 59.7)  16 ( 57.1)  4.7 0.940 2100 (56.4)   91 (55.2)  4.4 
  Male 244 ( 40.3)  12 ( 42.9)  4.2  1622 (43.6)   74 (44.8)  4.2 0.8 
Hospital admitted 
  
 
   
 
  BPH 181 ( 29.9)   2 (7.1)  1.1 0.050  662 (17.8)   17 (10.3)  2.5 <0.001 
 EVRMC 312 ( 51.6)  21 ( 75.0)  6.3 
 
2210 (59.4)  125 (75.8)  5.4  
 ONP  86 ( 14.2)   4 ( 14.3)  4.4 
 
 681 (18.3)   15 ( 9.1)  2.2  
 RITM  26 ( 4.3)   1 ( 3.6)  3.7 
 
 169 ( 4.5)   8 ( 4.8)  4.5 
 
Note: CRF, Case Fatality rate, BPH, Biliran Provincial Hospital; EVRMC, 
Eastern Visayas Regional Medical Center; ONP, Ospital Ng Palawan; RITM, 
Research Institute for Tropical Medicine; for only EVRMC patients.  
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Appendix  
SATREPS 
HOSPITAL STUDY  
ENTRY CRITERIA FORM 
RITM/ TU/BPH 
Joint Research Project 
Hospital Study # (A2/A3) 
TBp--/__/__/-/__/__/__/__/ 
[ ] ER  
[ ] OPD (A9) 
Date of Admission (A5) 
__/__/-/__/__/-/__/__/__/__/ 
 mm dd yyyy 
Time of Admission (A6)  
/__/__/-/__/__/ 
hh mm 
1. Patient Identification 
Name of Patient  (B1)  Date of Birth /__/__/-/__/__/-/__/__/__/__/  
 mm dd yyyy (B2) 
 Gender (B3) 
[ ] Male [ ] Female  
2. Entry Criteria 
Age of patient Respiratory signs Criteria for admission/ Study enrolment 
  
 [ ] 8 days old to 
less than 2 months 
old  
(EP_1) 
[ ] cough  (EP_1_A1) 
 and/or  
[ ] fast breathing (≥60/min) (EP_1_B1) 
[ ] difficult breathing < 3 weeks 
 (EP_1_A2) 
[ ] chest indrawing or (EP_1_B2) 
[ ] cyanosis or  (EP_1_B3) 
[ ] inability to drink/suck. (EP_1_B4) 
[ ] 2 months old to 
less than 5 years old  
(EP_2) 
[ ] cough and/or (EP_2_A1) [ ] chest indrawing or (EP_2_B1) 
[ ] difficult breathing<3 weeks  
(EP_2_A2) 
[ ] cyanosis or  (EP_2_B2) 
[ ] inability to drink/suck (EP_2_B3) 
[ ] 5 to 12 years old 
(EP_3) 
[ ] cough and/or (EP_3_A1) [ ] Co-morbid illness  
 (including malnutrition) or (EP_3_B1) [ ] difficult breathing < 3 weeks   
  (EP_3_A2)  
 and 
[ ] Failure to feed or (EP_3_B2) 
[ ] fever temp>37.8
o
C) (EP_3_A3) [ ] Moderate to severe dehydration  
  or  (EP_3_B3) [ ] tachypnea (RR>30/ min) (EP_3_A4) 
[ ] crackles  (EP_3_A5)  [ ] Signs of respiratory failure  
 (chest in drawing, cyanosis,  
 apnea, sensorial change) or (EP_3_B4) 
[ ] Complications (effusion, pneumothorax)  
   (EP_3_B5) 
[ ] 13 years old 
(EP_4) 
[ ] cough and/or (EP_4_A1) [ ] Co-morbid illness  
 (including malnutrition) or (EP_4_B1) [ ] difficult breathing < 3 weeks and  
   (EP_4_A2) [ ] Failure to feed or (EP_4_B2) 
[ ] fever temp>37.8
o
C) (EP_4_A3) [ ] Moderate to severe  
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[ ] tachypnea (RR>30/ min) (EP_4_A4)  dehydration or  (EP_4_B3) 
[ ] tachycardia (HR> 100/min) and  
 (EP_4_A5) 
[ ] Signs of respiratory failure  
 (chest in drawing, cyanosis,  
 apnea, sensorial change) or (EP_4_B4) [ ] abnormal chest finding (diminished 
breath sounds, rhonchi, crackles, or 
wheezes)  ( EP_4_A6) 
[ ] Complications (effusion, pneumothorax)  
   (EP_4_B5) 
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3. Initial Assessment  
Initial diagnosis  [1] Pneumonia, severe 
 [2] Pneumonia, very severe 
 [3] Other 
 
4. Exclusion Criteria (DO NOT ENROL PATIENT.) 
[ ] Children ≤ 7 days old and children ≥ 14 years old   ( Exc_P1) 
[ ] Non severe pneumonia     ( Exc_P2) 
[ ] Nosocomial pneumonia     ( Exc_P3) 
 [ ] admission to ONP for another illness and development of pneumonia symptoms while in the hospital 
       (Exc_P3_a) 
 [ ] prior admission to another hospital within the last three days prior to present admission to XXXX 
      ( Exc_P3_b) 
[ ] Prior hospital admission without a 1-week symptom free period when readmitted to hospital  
      (Exc_P4) 
 
5. Enrollment Procedures 
Informed consent from  [1] Obtained 
 [2] Refused 
Reason for Refusal 
  
 
 
 
6. Interviewer 
Project Staff  [1] Initial_________ 
 [2] If others, then name in print and signature. 
 _________________________________ 
 
7. Data encoding 
Database -1 
Project Staff Initial  
Encoding Date 
__/__/-/__/__/-/__/__/__/__/ 
mm dd yyyy 
Database -2 
Project Staff Initial  
Encoding Date 
__/__/-/__/__/-/__/__/__/__/ 
mm dd yyyy 
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SATREPS 
HOSPITAL ADMISSION  
DATA COLLECTION FORM 
RITM/ TU / BPH 
Joint Research Project 
Hospital Study # (A2/A3) 
TBp--/__/__/-/__/__/__/__/ 
Date of Admission (A5) 
/__/__/-/__/__/- /__/__/__/__/ 
mm dd yyyy 
 
1. Patient Identification 
Name of Patient  
06 Patient initials /__/__/__/ - /__/__/ 
3 letters in FIRST name and 2 letters in FAMILY name  
 Example: Akira Y. Suzuki  *akisu* 
07 Date of Birth /__/__/-/__/__/-/__/__/__/__/ (mm-dd-yyyy) 
08 Gender [ ] Male [ ] Female 
 
2. Chief Complaint 
01 Chief complaint  
 
3. Illness History (Caregiver* observed during the course of this episode OR interviewer observed). 
01 Fever □[1] Yes □ [2] No □[99] DK If yes, duration /__/__/days 
02 Nasal Discharge □[1] Yes □ [2] No □[99] DK If yes, duration /__/__/days 
02-a  →If yes, what is the characteristic? ______________________________________ 
03 Cough □[1] Yes □ [2] No □[99] DK If yes, duration /__/__/days 
04 Wheeze □[1] Yes □ [2] No □[99] DK If yes, duration /__/__/days 
05 Difficult Breathing □[1] Yes □ [2] No □[99] DK If yes, duration /__/__/days 
06 Inability to drink or feed □[1] Yes □ [2] No □[99] DK If yes, duration /__/__/days 
07 Sleeping most of the time, or 
difficult to wake
# 
□[1] Yes □ [2] No □[99] DK If yes, duration /__/__/days 
08 Convulsion □[1] Yes □ [2] No □[99] DK 
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09 Pallor □[1] Yes □ [2] No □[99] DK 
*Caregiver is defined as person who takes care of the child more than 1 year or since birth. 
 
4. Medication History 
01 
Antibiotic given (within the last three days prior to hospital admission for this episode) 
□[1] Yes □ [2] No □[99] DK If yes, specify______________ 
Other medications given 48 hours before the admission for this episode 
02 Antipyretics □[1] Yes □ [2] No □[99] DK If yes, specify______________ 
03 Bronchodilator □[1] Yes □ [2] No □[99] DK If yes, specify______________ 
04 Traditional Medicine □[1] Yes □ [2] No □[99] DK If yes, specify______________ 
 
5. Vital Signs/ Pulse oximetry /Anthropometry 
01 
Axillary temperature 
02 
Respiratory rate 
03 
Heart rate 
/__/__/./__/ o C /__/__/__/ per minute /__/__/__/ per minute 
04 
Weight 
05 
Height/Length 
 
/__/__/./__/ kg /__/__/./__/ cm 
06 
Blood Pressure 
(3 years old and above) 
Diastolic Systolic 
06-D /__/__/__/ mmHg 06-S /__/__/__/ mmHg 
07 
Oximetry 
08 
Oximetry pulse  
09 
 
Oximetry measurement 
/__/__/./__/ % 
□ [1] before oxygen / bronchodilator therapy 
□[2] during or after oxygen or 
□[8] not measured /__/__/./__/ per min 
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6. Physical Examination (to be completed on admission by MD) 
01 Grunting □[1] Yes □ [2] No  
02 
 
Decreased breath 
sounds 
Right Lobe 02-R □[1] Yes □ [2] No  
Left Lobe 02-L □[1] Yes □ [2] No  
03 Wheeze 
Right Lobe 03-R □[1] Yes □ [2] No  
Left Lobe 03-L □[1] Yes □ [2] No  
04 Rales/Crepitation 
Right Lobe 04-R □[1] Yes □ [2] No  
Left Lobe 04-L □[1] Yes □ [2] No  
 
05 Alar Flaring □[1] Yes □ [2] No  
06 Chest indrawing □[1] Yes □ [2] No  
07 Central Cyanosis □[1] Yes □ [2] No  
08 Apneic episodes □[1] Yes □ [2] No  
09 Neck rigidity# □[1] Yes □ [2] No  
10 
Sensorial change # 
(irritability, restlessness, drowsy, stupor or coma)  
□[1] Yes □ [2] No  
 
For those who answered yes on 3-07(Sleeping/Difficult to wake)#, 6-09#, or 6-10# 
11.1 Glasgow Coma Scale* Eye opening response  □[1] □[2] □[3] □[4] 
11.2 Glasgow Coma Scale* Verbal response  □[1] □[2] □[3] □[4] □[5] 
11.3 Glasgow Coma Scale* Motor response  □[1] □[2] □[3] □[4] □[5] □[6] 
- Glasgow Coma Scale* Total Score (No need to encode data) 
12 Ear pain/tenderness (for 3 years and older) □[1] Yes □ [2] No □[99] NA 
13 Ear discharge □[1] Yes □ [2] No  
14 Poor skin turgor □[1] Yes □ [2] No  
15 Organomegaly  □[1] Yes □ [2] No □[99] NA 
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16 Other significant finding (s)  
 
7. Clinical Assessment  
01 Initial diagnosis 
 [1] Pneumonia, severe 
 [2] Pneumonia, very severe 
 [3] Others, specify _____________________________ 
  _____________________________ 
 
 
8. Project Staff 
01 Attending physician 
 [1] Project MD (initial) _________ 
 [2] Resident on duty (name in print/signature) 
 _________________________________ 
 
9. Data encoding 
Database -1 
Project Staff Initial  
Encoding Date 
__/__/-/__/__/-/__/__/__/__/ 
mm dd yyyy 
Database -2 
Project Staff Initial  
Encoding Date 
__/__/-/__/__/-/__/__/__/__/ 
mm dd yyyy 
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*Glasgow Coma Scale 
 0-23 mos 2-5 years >5  
Eye Opening 
Response 
Spontaneous--open with blinking at baseline 4 
Opens to verbal command, speech, or shout 3 
Opens to pain, not applied to face 2 
None 1 
Verbal 
Response 
Smiles or coos appropriately 
Appropriate words or 
phrases 
Oriented 
5 
Cries and consolable Inappropriate words 
Confused 
conversation, but able 
to answer questions 
4 
Persistent inappropriate 
crying &/or screaming 
Persistent cries and/or 
screams 
Inappropriate 
responses, words 
discernible 
3 
Grunts or is agitated or 
restless 
Grunts 
Incomprehensible 
speech 
2 
No response No response None 1 
Motor 
Response 
Obeys commands for movement 6 
Purposeful movement to painful stimulus 5 
Withdraws from pain 4 
Abnormal (spastic) flexion, decorticate posture 3 
Extensor (rigid) response, decerebrate posture 2 
None 1 
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SATREPS CHILDHOOD PNEUMONIA 
PROJECT 
Questionnaire for Risk Assessment for Admitted 
Patient 
RESEARCH INSTITUTE FOR TROPICAL MEDICINE AND TOHOKU UNIVERSITY 
     Ver. 1.0 
Gneral instruction for the interviewer Feb11.201
4 1, Interviewer can do interview with the conditions below 
(1) The patient is stable (no more severe pneumonia) 
(2) Caregiver for the sick child is available 
2, You should fill up the ID block before the interview 
3, Encircle the code of the answer (draw only a small circle around the code and avoid encompassing the other codes within the 
circle) 
4, Codes used as general rule 
0 = NO 1 = YES 66 = OTHER SPECIFY 77 = NO DATA 88 = NOT APPLICABLE 99 = DON'T KNOW 
5, There are skipping instrucitons at the far right column. You should encircle "88" (=Not applicable) for the Skipped questions. 
6, File this form on the last section in the Patient files 
BLOCK PT: Patient 
Identification Q ID Question Answer GO TO 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PT 
1 Hospital admitted 1 EVRMC----------------------------------------------------- 1  
2 BPH--------------------------------------------------------- 2  
3 ONP--------------------------------------------------------- 3  
4 RITM-------------------------------------------------------- 4  
2 Hospital case # (assigned by the hospital)     
3 Hospital study # (assigned for the project) / / / /-/ / /-/ / / / / 
4 Patient initial (Ex. Hitoshi Oshitani = Hit Os) / / / / - / / / 
5 Patient sex  □Male □Female 
6 Date of birth of the patient | | |/| | |/| | | | | 
7 Province (Pt current address) If no Code, Name+777 for code Name Code | | | | 
8 Municipality or City (Pt current address), If no Code, Name+7779 for code Name Code | | | | 
9 Barangay (Pt current address), If no Code, Name+777 for code Name Code | | | | 
10 Date of Admission (mm/dd/yyyy) | | |/| | |/| | | | | 
11 Date of Interview (mm/dd/yyyy) | | |/| | |/| | | | | 
12 Time Started | | |:| | | AM/PM 
13 Time Ended | | |:| | |AM/PM 
14 Language of the interview 1 Bisaya----------------------------------------------------- 1  
2 Waray------------------------------------------------------- 2  
3 Tagalog---------------------------------------------------- 3  
4 English----------------------------------------------------- 4  
66 Others, specify  66  
15 Review of the questionnaire 1 No blanks-------------------------------------------------- 1  
2 With blanks, but were filled out---------------------- 2  
16 Outcome of the interview 1 Completed------------------------------------------------- 1 PT 19 
2 Refused---------------------------------------------------- 2 PT 17 
3 Incomplete------------------------------------------------ 3 PT 18 
17 Reason for refusal 1 No Time of Respondant ------------------------------ 1 PT 19 
2 Respondant Not Interested--------------------------- 2 PT 19 
66 Others, specify  66 PT 19 
88 Not Applicable-------------------------------------------- 88  
18 Reason for incomplete 1 Pt never stable during the admission-------------- 1 PT 19 
2 Pt died during the admission------------------------- 2 PT 19 
3 No caregiver is available during the admission- 3 PT 19 
66 Others, specify  66 
88 Not Applicable-------------------------------------------- 88 
PT 19 
19 Name and Signature of Interviewer Name Sign 
20 Name and Signature of Reviewer Name Sign 
21 Reviewer's Remarks 1 For encoding---------------------------------------------- 1  
2 Need to confirm data with interviewer------------- 2 
3 Need to confirm with Tohoku/RITM supervisor- 3 
 
22 Date of Review (MM/DD/YYYY) | | |/| | |/| | |__| | 
23 Name and Signature of Encoder 1 Name Sign 
24 Date Received1 | | |/| | |/| | |__| | 
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25 Date Encoded1 | | |/| | |/| | |__| | 
26 Name and Signature of Encoder 2 Name Sign 
27 Date Received 2 | | |/| | |/| | |__| | 
28 Date Encoded 2 | | |/| | |/| | |__| | 
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BLOCK HR: HOUSEHOLD ROSTER 
HR 
1 2 3 4 5 6 7 8 9 10 11 12 13 
 
 
 
 
 
 
 
 
 
 
 
 
 
ID 
What is 
the 
relationsh 
ip to the 
head of 
HH? 
 
 
 
Age 
 
 
 
Birth Date 
 
 
Sex 
 
 
 
Caregive 
r ID 
 
 
Status of 
the 
biological 
mother 
 
Highest 
Level of 
Education 
for 
household 
member 
 
 
 
Has (ID No) 
had asthma? 
 
 
 
Does (ID 
No) smoke? 
 
Does (ID 
No) sleep in 
the same 
room with 
this sick 
child? 
 
 
Does (ID 
No) sleep 
besides 
sick child? 
 
Does (ID 
No) usually 
wash hand 
when get 
back home 
 
Start with 
H/head 
(01 printed) 
then from 
elderies 
 
USE CODE 
Enter the number and 
encircle Y, M or D 
 
Y= year for >=1yo 
M = month for <1yo 
D = day for <30days 
 
MM/DD/YYYY 
 
Only for the Under 5 
children 
 
Male 
=1 
 
Female 
=2 
 
Only for 
<5yo 
 
Use ID 
in HR1 
 
Only for 
<15yo 
 
 
USE CODE 
 
 
USE 
CODE 
 
 
Yes=1 
No =0 
DK=99 
 
 
Yes=1 
No =0 
 
For the 
sick child, 
encircle 
both 1 /0 
 
For the 
sick child, 
encircle 
both 1 /0 
 
 
Yes=1 
No =0 
01 0 | 1 | | | Y / M / D | | |/| | |/| | | | | 1 / 2 |   1 / 0 / 99 1 / 0 1 / 0 1 / 0 1 / 0 
02 | | | | Y / M / D | | |/| | |/| | | | | 1 / 2 |   1 / 0 / 99 1 / 0 1 / 0 1 / 0 1 / 0 
03 | | | | Y / M / D | | |/| | |/| | | | | 1 / 2 |   1 / 0 / 99 1 / 0 1 / 0 1 / 0 1 / 0 
04 | | | | Y / M / D | | |/| | |/| | | | | 1 / 2 |   1 / 0 / 99 1 / 0 1 / 0 1 / 0 1 / 0 
05 | | | | Y / M / D | | |/| | |/| | | | | 1 / 2 |   1 / 0 / 99 1 / 0 1 / 0 1 / 0 1 / 0 
06 | | | | Y / M / D | | |/| | |/| | | | | 1 / 2 |   1 / 0 / 99 1 / 0 1 / 0 1 / 0 1 / 0 
07 | | | | Y / M / D | | |/| | |/| | | | | 1 / 2 |   1 / 0 / 99 1 / 0 1 / 0 1 / 0 1 / 0 
08 | | | | Y / M / D | | |/| | |/| | | | | 1 / 2 |   1 / 0 / 99 1 / 0 1 / 0 1 / 0 1 / 0 
09 | | | | Y / M / D | | |/| | |/| | | | | 1 / 2 |   1 / 0 / 99 1 / 0 1 / 0 1 / 0 1 / 0 
10 | | | | Y / M / D | | |/| | |/| | | | | 1 / 2 |   1 / 0 / 99 1 / 0 1 / 0 1 / 0 1 / 0 
11 | | | | Y / M / D | | |/| | |/| | | | | 1 / 2 |   1 / 0 / 99 1 / 0 1 / 0 1 / 0 1 / 0 
12 | | | | Y / M / D | | |/| | |/| | | | | 1 / 2 |   1 / 0 / 99 1 / 0 1 / 0 1 / 0 1 / 0 
13 | | | | Y / M / D | | |/| | |/| | | | | 1 / 2 |   1 / 0 / 99 1 / 0 1 / 0 1 / 0 1 / 0 
14 | | | | Y / M / D | | |/| | |/| | | | | 1 / 2 |   1 / 0 / 99 1 / 0 1 / 0 1 / 0 1 / 0 
15 | | | | Y / M / D | | |/| | |/| | | | | 1 / 2 |   1 / 0 / 99 1 / 0 1 / 0 1 / 0 1 / 0 
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HR 2 01 Head 04 Son-In-Law / Daughter-In-Law 08 Brother / Sister 12 Other relative Specify 
 02 Wife / Husband 
03 Son / Daughter 
05 Grandchild 
06 Parent 
09 Brother-In-Law / Sister-In-Law 
10 Uncle / Aunt 
13 Adopted / Foster / Stepchild 
14 Not related 
HR7 1.Alive and live in the household 07 Parent-In-Law 11 Niece / Nephew 99 DK 
2.Alive and live out of household HR8 0 = None 3 = Graduate Elementary 6 = Vocational 
3.Died 1 = Pre-school 4 = First- to fourth-year high school 7 = College or higher 
4.DK 2 = Elementary student 5 = High school graduate 99 = DK 
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BLOCK HH: Household 
 
Q ID 
 
Question 
 
Answer Skip 
  
 
 
1 
How many people in the family are aged 0 to 14? 0 None--------------------------------------------------------------- 0  
 1 One-----------------------------------------------------------------1  
 2 Two-----------------------------------------------------------------2  
 3 Three---------------------------------------------------------------3  
 4 Four---------------------------------------------------------------- 4  
 5 Five or more------------------------------------------------------5  
  
2 
Do all children in the family of ages 6 to 14 go to 
school? 
0 None--------------------------------------------------------------- 0  
 1 Yes----------------------------------------------------------------- 1  
 2 No children ages 6 to 14-------------------------------------- 2  
  
 
3 
What is the education level of the female head/spouse? 1 Graduate primary or less--------------------------------------1  
 2 First- to fourth-year secondary-------------------------------2  
 3 Graduate secondary------------------------------------------- 3  
 4 First-year college or higher----------------------------------- 4  
 
 
4 
Do any family members have salaried employed? (not 
self employed) 
0 No------------------------------------------------------------------ 0  
 1 Yes----------------------------------------------------------------- 1  
 
 
 
5 
What are the house’s outer walls made of, mainly? Light materials (Salvaged, makeshift, cogon, nipa, 
or 
1 
anahaw)-------------------------------------- 
1 
 
 Strong materials (iron, aluminum, tile, concrete, 2 
brick, stone, wood, asbestos)------------------------------- 
2 
 
 
 
 
6 
What is the house’s roof made of, mainly? Light materials (Salvaged, makeshift, cogon, nipa, 
or 
1 
anahaw)-------------------------------------- 
1 
 
 Strong materials (iron, aluminum, tile, concrete, 2 
brick, stone, wood, asbestos)------------------------------- 
2 
 
 
 
7 
What kind of toilet facility does the family have? 1 Water sealed ---------------------------------------------------- 1  
 2 None, open pit, closed pit, or other------------------------- 2  
 
 
8 
Does the family own a refrigerator? 0 No------------------------------------------------------------------ 0  
 1 Yes----------------------------------------------------------------- 1  
  
9 
How many television sets does the family have? 0 None--------------------------------------------------------------- 0  
 1 One-----------------------------------------------------------------1  
 2 Two or more------------------------------------------------------2  
 
 
10 
Does the family own a washing machine? 0 No------------------------------------------------------------------ 0  
 1 Yes----------------------------------------------------------------- 1  
 11 How many of the following pets does this 
household have? 
Write the number of pets in the boxes. If its Zero, 
Encircle 
the pets name and Write zero at the corresponding Box 
1 Dog----------------------------------------------------------| || |  
 2 Cat-----------------------------------------------------------| || |  
 66 Others Specify  | || |  
 12 How many rooms in the house? Write number of rooms in the boxes |__|__|  
 13 How many rooms in the house are used for sleeping? Write number of rooms in the boxes |__|__|  
 14 Where is the kitchen located? 1 In a separate room used as kitchen------------------------ 1 
2 Elsewhere in the house----------------------------------------2 
3 In a separate building------------------------------------------ 3 
 
 
HH16 
 4 Outdoors---------------------------------------------------------- 4 HH16 
 5 
No cooking done in the household (ig. eat other 
palce always)--------------------------------------------------- 
5 
 
HH17 
 66 Other (specify )  66  
 15 Is/are there window(s) in the kitchen? 0 No------------------------------------------------------------------ 0  
 1 Yes----------------------------------------------------------------- 1  
 88 Not applicable----------------------------------------------------
88 
 
 16 What type of fuel does your household mainly use 
for cooking? 
1 Electricity----------------------------------------------------------1  
 2 Liquefied Petroleum Gas (LPG)----------------------------- 2  
 3 Kerosene----------------------------------------------------------3  
 4 Charcoal---------------------------------------------------------- 4  
 5 Wood-------------------------------------------------------------- 5  
 6 No food cooked in household-------------------------------- 6  
 66 Others, specify  66  
 17 FOR CAREGIVER 0 No------------------------------------------------------------------ 0 Next 
 Do you usually wash your hand before taking care of the 
baby/child? 
 
1 Yes----------------------------------------------------------------- 1 
Blk 
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 18 What is used for hand washing? 1 Only water-------------------------------------------------------- 1  
 2 Water With soap /detergent---------------------------------- 2  
 3 Alcohol or hand sanitizer-------------------------------------- 3  
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BLOCK TY: Typhoon related 
questions  
Q ID 
 
Question 
 
Answer 
Go 
to 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TY 
 
 
 
 
1 
Level of damage to your house after the typhoon  
1 No damage------------------------------------------------------------------------------- 1 
 
TY3 
 
walls, some minor damages(s) such as hole 
 
2 Moderately damaged------------------------------------------------------------------- 2 
 
 
walls are still there 
 
3 Severely damaged---------------------------------------------------------------------- 3 
 
 4 Total damage---------------------------------------------------------------------------- 4 
 
walls,   
 
 
 
 
2 
Current staus of the damage of the original house 
1 All fixed already-------------------------------------------------------------------------- 1  
2 Use of temporary materials as roof (blue sheet etc)--------------------------- 2 
3 Use of temporary materials for whole house ------------------------------------ 3 
 
4 Abandoned-------------------------------------------------------------------------------- 4  
66 
Others, Specify   
66
 
 
88 Not applicable---------------------------------------------------------------------------- 88  
 
 
 
3 
Where do you stay now? 
1 Same address with same family---------------------------------------------------- 1  
2 Same address with additional family----------------------------------------------- 2  
3 Different address with same family------------------------------------------------- 3  
4 Different address with additional family------------------------------------------- 4  
 
4 
Have you ever lived in the evacuation center? 
0 NO------------------------------------------------------------------------------------------- 0 TY6 
1 YES----------------------------------------------------------------------------------------- 1  
 
 
 
 
5 
How long had you lived in the evacuation center? 
1 1day----------------------------------------------------------------------------------------- 1  
2 2-5days------------------------------------------------------------------------------------ 2  
3 1 week-2weeks-------------------------------------------------------------------------- 3  
4 More than 2weeks, Specify weeks ------------------------------ 4  
88 Not applicable---------------------------------------------------------------------------- 88  
 
 
 
6 
What was your primary source of income before the 
Typhoon ? 
1 Farming------------------------------------------------------------------------------------ 1  
2 Fishery------------------------------------------------------------------------------------- 2  
3 Transport driver-------------------------------------------------------------------------- 3  
4 Others (Specify   4  
 
 
7 
How is your household income affected by the typhoon ?  
1 Not affected------------------------------------------------------------------------------- 1  
Ask how long they probably will not have normal income 
because of the effect of the typhoon. 
 
2 Moderately (3 months at most after the typhoon)------------------------------- 2 
 
 
 
3 Severely (more than 3 months after the typhoon)------------------------------ 3 
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BLOCK HB: Health seeking 
behavior Q ID Question Answer GO TO 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HB 
 
 
 
 
 
 
 
 
1 
What symptoms made you decide to bring the child to this 1 Cough--------------------------------------- YES NO  
 2 Colds---------------------------------------- YES NO  
Ask this question, and the respondant immedately answer 
"Don’t Know, just referred or told to consult", then encircle 
3 Chest indrwaing-------------------------- YES NO  
YES" in "7" and "NO" for the rest f the questions. If they can 
tell you any symptoms, start to read each item and encircle the 
4 Inabitity to dirink/be fed----------------- YES NO  
answer YES or NO 5 Fast breathing----------------------------- YES NO  
 6 Fever---------------------------------------- YES NO  
 7 Don’t know, just told (referred) ------ YES NO  
 8 
Others1, specify here 
YES NO  
 9 
Others2, specify here 
YES NO  
 10 
Others3, specify here 
YES NO  
 
 
 
2 
How soon did you leave for the hospital after you decided 1 Within 30min----------------------------------------------------- 1 HB4 
to bring the child or told to go to this hospital? 2 On the day-------------------------------------------------------- 2  
 3 1 day later-------------------------------------------------------- 3  
Time to take action, NOT reaching the health facility 4 2 days later------------------------------------------------------- 4  
 5 3 dyas later------------------------------------------------------- 5  
 6 4 days later------------------------------------------------------- 6  
 7 5 dyas late or more-------------------------------------------- 7  
 
 
 
3 
Why were you unable to take the child to the hospital 
immediately? 
Multiple answers are allowed. For all answers mentioned 
by the respondent, encircle the code. 
If the respondent gives an answer that is not on the list, encircle 
it on the space for Others 
1 Look for Finalcial support to pay transport-------------- 1 
2 Look for Finalcial support to pay hospital fee----------- 2 
 
3 Cannot leave work at that time----------------------------- 3  
4 Cannot leave other children at that time----------------- 4  
66 Others, specify  66  
88 Not applicable--------------------------------------------------- 88  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 
Tell m  your action(s) taken for the child between the point Noticed your child was unwell  
you seek for help outside and reaching this hospital by 
1
s
t 
V
is
it
 
1, BHS------------------------------------------------------------- 1  
chronological order? 2, RHU------------------------------------------------------------- 2  
 3, Sattelite clinic------------------------------------------------- 3  
You should say "Where did you go first?" And continue to say 4, Traditional healer------------------------------------------- 4  
"Then" until the child reached this hospital. 
5, Pharmacy --------------------------------------------------- 5  
 6, Private Clinic------------------------------------------------- 6  
 7, Hospital other than this hospital------------------------ 7  Encircle a cohice chronologically from 1st to 4th visit. 66, Others, specify  66 
88Not applicable------------------------------------------------ 88 
 
You should encircle 88 for "not applicalbe" if the item(s) not 
2
n
d
 V
is
it
 
1, BHS------------- 1  
used. 2, RHU------------------------------------------------------------- 2  
 3, Sattelite clinic------------------------------------------------- 3  
 4, Traditional healer------------------------------------------- 4  
 5, Pharmacy --------------------------------------------------- 5  
 6, Private Clinic------------------------------------------------- 6  
 7, Hospital other than this hospital------------------------ 7  
 66, Others, specify  66  
 88Not applicable------------------------------------------------ 88  
 
3
rd
 V
is
it
 
1, BHS------------------------------------------------------------- 1  
 2, RHU------------------------------------------------------------- 2  
 3, Sattelite clinic------------------------------------------------- 3  
 4, Traditional healer------------------------------------------- 4  
 5, Pharmacy --------------------------------------------------- 5  
 6, Private Clinic------------------------------------------------- 6  
 7, Hospital other than this hospital------------------------ 7  
 66, Others, specify  66  
 88Not applicable------------------------------------------------ 88  
 
4
th
 V
is
it
 
1, BHS------------------------------------------------------------- 1  
 2, RHU------------------------------------------------------------- 2  
 3, Sattelite clinic------------------------------------------------- 3  
 4, Traditional healer------------------------------------------- 4  
 5, Pharmacy --------------------------------------------------- 5  
 6, Private Clinic------------------------------------------------- 6  
 7, Hospital other than this hospital------------------------ 7  
 66, Others, specify  66  
 88Not applicable------------------------------------------------ 88  
 Reached this hospital  
 
 
 
 
 
hospital?
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BLOCK MN: Maternal and child 
health Q ID Question Answer GO TO 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MN 
 
 
1 
Can you show me the Mother and Child (MC) Book (or 
any documented prenatal/delivery records)? 
If No, Continue, if Yes, then fill up based on the the 
record. If some information are missing then ask the 
caregiver. 
 
0 No-------------------------------------------------------------------------------- 0 
 
 
1 Yes (book seen)--------------------------------------------------------------1 
 
2 
Did you attend prenatal care during your pregnancy for 
this child? 
0 No-------------------------------------------------------------------------------- 0 MN5 
1 Yes------------------------------------------------------------------------------ 1 Next 
 
 
 
 
 
3 
Where did you attehd for prenatal care during the 
pregnancy? 
Public sector  
1 Govt. hospital---------------------------------------------------------------1  
2 RHU-------------------------------------------------------------------------2  
3 BHS------------------------------------------------------------------------- 3  
4 Other public (specify)  4  
Private Medical Sector 
5 Private hospital---------------------------------------------------------- 5 
6 Private clinic-------------------------------------------------------------- 6 
7 Private maternity clinic (lying in)-------------------------------------7 
 
8 Other private (specify)  8  
88 Not Applicable---------------------------------------------------------------- 88  
 
4 
How many times did you attehd for prenatal care during 
the pregnancy? 
Write the number of times in the boxes |__||__|  
88 Not Applicable---------------------------------------------------------------- 88  
99 Don’t know---------------------------------------------------------------------99  
 
 
 
 
 
 
5 
Where did you give birth to this child? Home  
1 At home-------------------------------------------------------------------- 1  
2 Other house-------------------------------------------------------------- 2  
Public sector  
3 Govt. hospital--------------------------------------------------------------- 3  
4 RHU------------------------------------------------------------------------- 4  
5 BHS------------------------------------------------------------------------- 5  
6 Other public (specify)  6  
Private Medical Sector 
7 Private hospital---------------------------------------------------------- 7 
8 Private clinic-------------------------------------------------------------- 8 
9 Private maternity clinic (lying in)------------------------------------- 9 
10 Other private (specify)  10 
 
 
6 
What was the mode of delivery? 1 Vaginal------------------------------------------------------------------------- 1  
2 C-section----------------------------------------------------------------------- 2  
99 Don't Know-------------------------------------------------------------------- 99  
 
7 
How many weeks/months pregnant were you when this 
child was delivered? 
Write the number in weeks OR months based on the 
respondents reply, and put (88) on the other. 
 
| | |Weeks OR | | |Months 
 
MN9 
 
99 Don’t know---------------------------------------------------------------------99 
 
Next 
 
 
8 
If DK 1 Full term------------------------------------------------------------------------ 1  
 2 Pre-term------------------------------------------------------------------------ 2  
Was the delivery full term, pre-term or post-term? 3 Post-term---------------------------------------------------------------------- 3  
 88 Not Applicable---------------------------------------------------------------- 88  
 99 Don't Know-------------------------------------------------------------------- 99  
 
9 
How much did this child weigh when he/she was born? Record birth weight in grams | || || || |g MN11 
99 Don’t know---------------------------------------------------------------------99 Next 
 
 
10 
If DK 1 Small---------------------------------------------------------------------------- 1  
 2 Medium------------------------------------------------------------------------- 2  
What was the child size at birth? 3 Large---------------------------------------------------------------------------- 3  
 88 Not Applicable---------------------------------------------------------------- 88  
 99 Don't Know-------------------------------------------------------------------- 99  
 
11 
Has this child ever been breastfed? 0 No-------------------------------------------------------------------------------- 0 Next Blk 
1 Yes------------------------------------------------------------------------------ 1 Next 
99 Don't Know-------------------------------------------------------------------- 99 Next Blk 
 
12 
Is he/she still being breastfed? 0 No-------------------------------------------------------------------------------- 0  
1 Yes------------------------------------------------------------------------------ 1  
88 Not Applicable---------------------------------------------------------------- 88  
99 Don't Know-------------------------------------------------------------------- 99  
 
13 
How long was this child exclusively breast fed? 
Write the number in days or months based on the 
respondents reply, and put (88) on the other. 
1 | | |Days OR | | |Months  1  
2 Ongoing------------------------------------------------------------------------ 2  
88 Not Applicable---------------------------------------------------------------- 88  
99 Don't Know-------------------------------------------------------------------- 99  
 How long was this child breast fed totally (including the 
mixed with solid food)? 
1 | | |Days OR | | |Months  0  
2 Ongoing------------------------------------------------------------------------ 1  
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14 Write the number in days or months based on the 
respondents reply, and put (88) on the other. 
88 Not Applicable---------------------------------------------------------------- 88  
99 Don't Know-------------------------------------------------------------------- 99  
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BLOCK UD: Underlying 
disease  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UD 
 
1 
Does child have any congenital abnormality? 
(abnormality compared to other baby, such as down 
sysdrom) 
0 No---------------- ------------------------------ ---------------------------------- 0 UD 3 
1 Yes------------------------------------------------------------------------------ 1 Next 
99 Don't Know-------------------------------------------------------------------- 99 UD 3 
 
 
2 
What is the congenital abnormality? 1 Trisomy 21----------------------------------- ----------------------------------1   
2 Congenital heart disease-------------------------------------------------- 2   
3 Hydrocephalous---------------------------- ---------------------------------- 3   
66 Others, Specify   
88 Not Applicable------------------------------ 
99 Don't Know-------------------------------------------------------------------- 99 
  
 
3 
Has the child been diagnosed to have TB? 0 No---------------- ------------------------------ ---------------------------------- 0 UD 5 
1 Yes------------------------------------------------------------------------------ 1 Next 
99 Don't Know-------------------------------------------------------------------- 99 UD 5 
 
 
4 
Has the child been treated with completeing TB drug 
therapy? 
0 No---------------- ------------------------------ ---------------------------------- 0   
1 Yes------------------------------------------------------------------------------ 1   
2 Ongoing-------- ---------------------------------------------------------------- 2   
88 Not Applicable------------------------------ ---------------------------------- 88   
99 Don't Know-------------------------------------------------------------------- 99   
 
5 
Has the child been diagnosed to have asthma? 0 No---------------- ------------------------------ ---------------------------------- 0 UD 7 
1 Yes------------------------------------------------------------------------------ 1 Next 
99 Don't Know-------------------------------------------------------------------- 99 UD 7 
 
6 
Is the child under any medication for asthma? 0 No---------------- ------------------------------ ---------------------------------- 0   
1 Yes------------------------------------------------------------------------------ 1   
88 Not Applicable------------------------------ ---------------------------------- 88   
99 Don't Know-------------------------------------------------------------------- 99   
 
7 
Has s/he had chronic cough for 2 weeks in the past one 
year? 
0 No---------------- ------------------------------ ---------------------------------- 0   
1 Yes------------------------------------------------------------------------------ 1   
99 Don't Know-------------------------------------------------------------------- 99   
 
8 
Has the child ever been diagnosed with atopic dermatitis? 0 No---------------- ------------------------------ ---------------------------------- 0   
1 Yes------------------------------------------------------------------------------ 1   
99 Don't Know-------------------------------------------------------------------- 99   
 
9 
Does the child have chronic redness or dry skin? 0 No---------------- ------------------------------ ---------------------------------- 0   
1 Yes------------------------------------------------------------------------------ 1   
99 Don't Know-------------------------------------------------------------------- 99   
 
10 
Does child have other disease(s) now, diagnosed by a 
physician? 
0 No---------------- ------------------------------ ---------------------------------- 0 Next Blk 
1 Yes------------------------------------------------------------------------------ 1 Next 
99 Don't Know-------------------------------------------------------------------- 99 Next Blk 
 
 
 
11 
What is/are this/these disease(s)? 
List down all 
 
 
 
 
 
88 Not Applicable---------------------------------------------------------------- 88 
  
99 Don't Know-------------------------------------------------------------------- 99   
BLOCK HA: Hospital 
admission  
 
 
 
 
 
 
 
 
 
 
HA 
 
1 
has your child ever been confined in hospital for whatever 
reason - from the time s/he was born until now ? 
0 N ---------------- ------------------------------ ---------------------------------- 0 Next Blk 
1 Yes------------------------------------------------------------------------------ 1 Next 
99 Don't Know--------------------------------------------- 99 Next Blk 
 
2 
How many times has the child been confined in the hospital ? 
Record the number of times on the boxes and write the 
details of the confinement on the table below 
If recalled, write the number -------------------------| | | Next 
88 Not Applicable---------------------------------------------------------------- 88 Next Blk 
99 Don't Know-------------------------------------------------------------------- 99 Next Blk 
Ask about th past admission history from the latest admission (except for the current admission).  
3 4 5 6 7 8  
No o f  
N a m e of H os pi ta l 
 
 
Month/ YEAR 
Duration betw een 
date of the onset and 
date of the adm ission 
If recalled (in DAYS) 
 
Duration of stay in 
hosp 
If recalled (in DAYS) 
 
D i a g nos i s 
 
h o spit al  
admissio  
n  
 01, E V R MC If NOT recalled 
in Month, 
encode 99 in MM 
if not in Year 
encode 9999 in YYYY 
 
If not recalled 
encode 999 
 
If not recalled 
encode 999 
01, Pneum oi na  
Fr o m 02, B PH 
  lat e st t o 03, ON P 02, Sev ere Pneum oni a  
o lde r 04, R ITM 
03, V ery Sev ere Pneum oni a 
66, Others Spec i f y  
 
66, Others s pec i f y 
  
1 | | | Specify |__|__| / |__|__|__|__| |__|__|__| |__|__|__| | | | Specify  
2 | | | Specify |__|__| / |__|__|__|__| |__|__|__| |__|__|__| | | | Specify  
3 | | | Specify |__|__| / |__|__|__|__| |__|__|__| |__|__|__| | | | Specify  
4 | | | Specify |__|__| / |__|__|__|__| |__|__|__| |__|__|__| | | | Specify  
5 | | | Specify |__|__| / |__|__|__|__| |__|__|__| |__|__|__| | | | Specify  
6 | | | Specify |__|__| / |__|__|__|__| |__|__|__| |__|__|__| | | | Specify  
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7 | | | Specify |__|__| / |__|__|__|__| |__|__|__| |__|__|__| | | | Specify  
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BLOCK IM: Immunization stutus 
IM1 Can you show me a vaccination record for this child? No record shown------------------------------- 0 
Yes, record was shown to interviewer----- 1 
If any record shown, use the information to complete the table of vaccination below. 
If no record given, or lacking information in the record, interview the caregiver. 
Follow this 
 
  Column 1 Column 2 Column 3 
 
Q ID 
 
Vaccines 
 
 
Given to the child? 
 
Can you remember Month 
and/or Year? 
 
Date 
NO YES DK NO YES NA MM/YYYY NA 
IM2 BCG 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM3_1 DPT (1st) 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM3_2 DPT (2nd) 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM3_3 DPT (3rd) 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM4_1 OPV (1st) 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM4_2 OPV (2nd) 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM4_3 OPV (3rd) 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM5_1 HBV(1st) 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM5_2 HBV(2nd) 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM5_3 HBV(3rd) 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM5_4 HBV(4th) 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM6 AMV(9Months) 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM7 MMR 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM8 Vitamin A 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM9 Deworming 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM10_1 Hib(1st) 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM10_2 Hib(2nd) 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM10_3 Hib(3rd) 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM10_4 Hib(4th) 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM11_1 Rota(1st) 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM11_2 Rota(2nd) 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM11_3 Rota(3rd) 0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM12 Others Specify:-   0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM13 Others Specify:-   0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM14 Others Specify:-   0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
IM15 Others Specify:-   0 1 99 0 1 88 | _|_ |/| _|_ | | | 88 
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BLOCK MT: Mortality 
Q No. Question Answer Go To 
 
 
 
 
 
MT 
 
 
 
1 
Have you ever given birth to a boy or girl who was born alive but later died before 
the birthday of 5 years of age? 
 
If “No” probe by asking: 
 
I m ean, to a child w ho ever breathed or cried or show ed other signs of life – even if he 
or she lived only a few m inutes or hours? 
 
0 
 
No------------------------------------------------------------------ 
 
0 
 
End 
 
1 
 
Yes---------------------------------------------------------------- 
 
1 
 
CM 2 
 
99 
 
Don’t know------------------------------------------------------ 
 
99 
 
End 
 
2 
How many boys have died?  Boys -------------------------------------- I__I I__I  Next 
If none, record ‘00’. 88 Not applicable-------------------------------------------------- 88  
 
3 
How many girls have died?  Girls -------------------------------------- I__I I__I  End 
If none, record ‘00’ . 88 Not applicable-------------------------------------------------- 88  
CRF1_entry 
CRF_Entery Criteria_ver2  
070912  
Page2 
 
